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Biofilm formation is a significant mechanism by which pathogens are able to evade 
the human immune system and to be unresponsive to antimicrobial treatments. Indeed, 
biofilm formation is a major contributor to antimicrobial resistance (AMR), a current 
and growing clinical problem around the world. Herein, the synthesis of linear and 
cyclic polyamines containing different spatial distances between the amino groups 
were designed on the basis of the chemical structures of certain naturally occurring 
polyamines. The complete reduction of aliphatic nitrile functional groups to primary 
amines can be performed via catalytic hydrogenation using Raney nickel catalyst 
under 1 atm pressure of hydrogen and in basic media. The NMR spectroscopic data of 
the synthesised polyamines that have not been fully assigned, or indeed are mis-
assigned in the literature, were fully and typically unambiguously assigned. Then their 
biological activities in preventing biofilm formation and for the dispersal of existing 
biofilms, with and without combination with the antibiotic vancomycin, were 
investigated. Two novel polyamines 33 and 35 show activity in preventing biofilm 
formation in NCTC 6571 and MSSA 15981 strains. In the NCTC 6571 strain, each of 
these two polyamines shows high activity when used in combination with vancomycin 
achieving higher activity in the killing of bacterial cells inside preformed biofilms than 
the use of vancomycin alone. Polyamine 49 shows antibacterial activity and prevents 
biofilm formation in the above two S. aureus strains and in the MRSA 252 strain, and 
shows high activity in the killing of bacterial cells within preformed NCTC 6571 
biofilms in combination with vancomycin. These results are a contribution to the fight 
against AMR. Whilst simple linear polyamines do not exhibit the biological activity 
some have claimed in this research area, these three polyamines 33, 35, and 49 
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13C-NMR    Carbon nuclear magnetic resonance 
1H-NMR    Proton nuclear magnetic resonance 
Agr     Accessory gene regulatory 
AHL     Acyl homoserine lactone 
AIP     Autoinducing peptide 
AMR     Anti-microbial resistance 
br     Broad 
c-di-AMP   Cyclic di-adenylate monophosphate 
c-di-GMP   Cyclic dimeric guanosine monophosphate 
CFU     Colony Forming Unit 
CLSM    Confocal Laser Scanning Microscopy 
dsDNA    double stranded DNA 
EPS     Extracellular Polymeric Substance 
eq     equivalent 
ESI     electrospray ionisation 
g     gram 
HR TOF    High resolution time-of-flight 
HRMS    High resolution mass spectrometry 
HSQC-NMR    Heteronuclear single quantum correlation NMR 
Hz     Hertz 
IR     Infra-red 
J     Coupling constant 
M     molar (mole per litre) 
m     multiplet 
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MHz     MegaHertz 
mm     millimetre 
mmol     millimole 
MRSA    Meticillin-resistant Staphylococcus aureus 
MSSA    Meticillin-sensitive Staphylococcus aureus 
NCTC    National Collection of Type Cultures 
NS     Norspermine 
NSD     Norspermidine 
O.D.    Optical density 
PBS    Phosphate buffered saline 
ppGpp    Guanosine tetraphosphate 
ppm     parts per million 
pppGpp    Guanosine pentaphosphate 
q    quartet 
QS     Quorum sensing 
Rf     Retention factor 
rpm     revolutions per minute 
s     singlet 
t     triplet 
TLC     Thin layer chromatography 
TSB     Tryptone soya broth 
UV     Ultraviolet 
v/v     volume/volume 
v/v/v     volume/volume/volume 
v/v/v/v    volume/volume/volume/volume 
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1.1 Introduction and Literature Review 
Natural products have played important roles in treating and even in preventing 
diseases for thousands of years. The closely associated development of pharmacology 
is, in part, based on structural modification of lead molecules derived from natural 
products. Drugs developed from natural sources mainly come from plants and also 
from microorganisms, marine life, vertebrates and invertebrates. 
 
Increasing bacterial resistance is creating a great challenge to global health (Tse et al., 
2017). Staphylococcus aureus is a major cause of bacterial infections in the community 
and infections associated with health facilities (Archer and Climo, 2001). Patients 
infected with meticillin resistant S. aureus (MRSA) are estimated to have a 64% higher 
mortality rate than patients who are infected with the sensitive form of the bacteria, 
meticillin sensitive S. aureus (MSSA) (WHO, report 2018). This ever growing threat 
gives rise to the need to discover new strategies in the treatment of bacterial infections. 
 
Bacterial cells live in two styles:  as free planktonic cells and in aggregation clusters 
called biofilms. These aggregations were described in 1978 by Costerton as a 
glycocalyx film formed by bacteria that can stick to biotic surfaces such as teeth and 
lungs (Costerton et al., 1978). Biofilms are a major source of the problem of anti-
microbial resistance (AMR) (Costerton et al., 1999), and about 80% of human bacterial 
infections are biofilm-related (Worthington et al., 2012; Barsoumian et al., 2015). 
Biofilms are multicellular communities of bacterial cells that are embedded in an 
18 
 
extracellular matrix of polymeric substances (Costerton et al., 1999). These 
extracellular polymeric substances (EPS) are generally composed of polysaccharides, 
proteins, and DNA (Oppenheimer-Shaanan et al., 2013). The matrix mass can 
represent more than 90% of the biofilm dry mass, while bacterial cells may represent 
less than 10% of the total weight (Flemming and Wingender, 2010). 
 
In Staphylococcal biofilms, the extracellular matrix of polymeric substances may 
contain the polysaccharide β(1-6)-N-acetylglucosamine, proteins, and/or extracellular 
DNA (Arciola et al., 2015). The synthesis of this intercellular adhesion polysaccharide 
depends on the expression of the gene icaADBC, the expression of which depends on 
environmental stimuli such as anaerobic conditions, high osmolality, and subinhibitory 
concentrations of antibiotics (Valle et al., 2003). 
 
Enzymes secreted by bacteria supply bacterial cells with nutrients by digesting 
polymers which could be derived from e.g., dead cells, some of the EPS components 
or other nutrient sources that are trapped in the biofilm matrix. The hydrophilicity of 
exopolysaccharide components of the EPS can retain water within the biofilm. The 
presence of water channels provides bacterial cells deep in the biofilm with nutrients. 
Overall, the biofilm matrix represents a hydrated and nutrient rich environment for 
bacteria (Flemming and Wingender, 2010). 
 
Several factors determine the composition of biofilms, including the type of bacteria 
forming the biofilm, the nature of the surface, nutrients, and temperature. This 
variation in EPS constituents affects biofilm response to external effects such as 
antibacterial agents (Naik et al., 2018; Wang et al., 2018). Therefore, it is important to 
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know accurately the constituents of a biofilm as this will significantly affect the 
methods and approaches by which biofilm disruptors can be designed. 
 
Biofilms play an important role in the environment. For example, a defensive 
technique for some plants to protect themselves from pathogens is by biofilms formed 
Bacillus subtilis in soil. Biofilms could be found anywhere in the environment, like 
soil, industrial places, waste water pipes, medical devices, and teeth surfaces 
(Beauregard et al., 2013; Mack et al., 2006). 
 
Biofilms are formed in three steps:  attachment to a surface, formation of micro 
colonies, and maturation to biofilm (Boles and Horswill, 2011). Biofilms are formed 
initially by the adherence of planktonic bacteria to a surface. Bacterial cells can attach 
to biotic or abiotic surfaces or even form aggregations at liquid/air interfaces 
(Costerton et al., 1999; Tan and Darby, 2004). Then bacteria irreversibly attach to the 
surface. At this step bacteria cannot be washed off by gentle washing (Donlan, 2002). 
Hydrophobicity, smoothness of the surface, and quorum sensing (QS) play important 
roles in this step (Lv et al., 2014; Mack et al., 2006). Cell wall associated proteins are 
involved in the attachment of Staphylococcus bacteria to polymeric surfaces (Mack et 
al., 2006). The composition of bacterial cell surface and the medium properties 
significantly influence the attachment step (Donlan, 2002). Bacterial cells start to 
anchor to each other driven by changes in gene expression that are dependent on QS 
and the formation of primary colonies (Figure 1). 
 
Biofilms mature by cell growth and division in different architectural forms that vary 
in roughness, shape, and degrees of porosity. This process is to some degree controlled 






Figure 1: Stages of biofilm formation:  1. Free planktonic cells attach to a surface.  
2. Under QS, bacterial cells start to anchor to each other forming small colonies and start to 
secrete EPS. 3. The biofilms mature by cell growth and division. 4. Biofilm may disperse 
allowing bacterial cells to form new biofilms. Adapted from Abouelhassan et al., 2017. 
 
Bacterial cells produce signalling molecules that are used in cell-to-cell 
communication, e.g. peptides in S. aureus (Kavanaugh and Horswill, 2016). At low 
concentrations, these signalling molecules are inactive, but when the population of 
bacteria increases, the concentration of signalling molecules reaches a certain 
threshold and activates gene expression in bacterial cells leading to secretion of EPS. 
The EPS matrix protects bacterial cells against the immune system and antibacterial 
agents, and provides nutrients by trapping digestive enzymes within the biofilm which 
generates an external digestive system able to supply bacterial cells with essential 
nutrients. The presence of minerals, like calcium ions, strengthens biofilms by forming 
cross linking bridges between acidic groups of exopolysaccharides chains (Flemming 
and Wingender, 2010). Finally, biofilms may disperse allowing bacterial cells to move 




Biofilms and bacterial resistance. The presence of bacterial cells within the biofilm 
provides them with protection from antimicrobial agents and the human immune 
defence system, such as phagocytes and antibodies. Bacterial biofilms are very tolerant 
to the body’s defence system and resist phagocytosis and antibiotics (Costerton et al., 
1999; Mah and O'Toole, 2001).  
 
Biofilms are up to 1000-times more resistant to antibiotics than planktonic cells (Hoiby 
et al., 2010), but resistance mechanisms such as modifying enzymes and target 
mutation are not specifically responsible for bacterial biofilm resistance. Three main 
hypothetical mechanisms by which biofilms resist antimicrobial agents have been 
proposed (Stewart and Costerton, 2001). The first hypothesis is that the biofilm matrix 
decreases antibiotic permeability into the biofilm. Positively charged antibiotics such 
as aminoglycosides may be adsorbed by negatively charged EPS leading to slower 
penetration of these antibiotics through a biofilm matrix. The second hypothesis is that 
the chemical environmental conditions inside the biofilm e.g., oxygen depletion and 
pH gradients inactivate some antibiotics. In anaerobic conditions, aminoglycosides are 
much less active against the same organism compared to under aerobic conditions 
(Stewart and Costerton, 2001). The third hypothesis is that some bacterial cells in 
biofilms differentiate into a spore-like or semi-dormant state. In this state, bacterial 
cells have a lower growth rate in the centre of the biofilm and are highly resistant to 
antibiotics which may explain the inactivity of antibiotics even if they reach high 
concentrations within the biofilm. Biofilms are involved in many serious infections 
e.g. cystic fibrosis, wound infections, and device-related infections such as valves and 
catheters (Donlan and Costerton, 2002; O'Neill et al., 2007; Percival et al., 2012). S. 
aureus and S. epidermidis are among the major causes of biofilm related infections 
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found clinically in Hickman catheters, central venous catheters, mechanical heart 
valves, vascular grafts, and orthopedic devices (Cha et al., 2013; Costerton et al., 
1999). This, combined with the high level of resistance, makes biofilms a serious 
healthcare problem for which better solutions urgently need to be found. 
 
Several compounds have been proposed and some tested for their ability to disrupt 
biofilms, mainly QS modifying molecules, amino acids, and polyamines (Bottcher et 
al., 2013; De la Fuente-Nunez et al., 2014; De la Fuente-Nunez et al., 2015; Hochbaum 
et al., 2011; Kavanaugh and Horswill, 2016; Kolodkin-Gal et al., 2010; Konai et al., 
2015; Nesse et al., 2015; Oppenheimer-Shaanan et al., 2013; Ramon-Perez et al., 2015; 
Sarkar and Pires, 2015; Si et al., 2015; Wu et al., 2016). Different classes of biofilm-
disrupting agents are discussed in more detail below. 
 
Quorum sensing modifying molecules. Acyl homoserine lactones (AHLs) (Figure 2) 
are signalling molecules for QS in Gram negative bacteria. Modified AHL molecules 
were able to block QS in P. aeruginosa and thereby inhibit biofilm formation 
(Worthington et al., 2012). Several Bacillus species produce the enzyme acyl 
homoserine lactonase which hydrolyses AHL, preventing cell communication by QS 
in Gram negative bacteria and thus preventing biofilm formation (Oppenheimer-
Shaanan et al., 2013). This approach is limited in its ability to prevent biofilm 
formation and it has limited effect on already formed biofilms. A second limitation for 
this method is that biofilm dispersion itself is thought to be a QS dependent process 
(Kavanaugh and Horswill, 2016; Yarwood et al., 2004) and therefore deactivation of 
QS could be unbeneficial. Hyper-activation of QS was proposed to disperse already 





Figure 2: Acyl homoserine lactones (AHL), R:  Alkyl chain. 
 
 
Figure 3: Autoinducing peptide type I (AIP-I). 
 
Autoinducing peptides (AIPs) (Figure 3) are part of the QS system and regulate the 
secretion of matrix degrading enzymes by targeting accessory gene regulatory (agr) 
system in S. aureus. Via the agr system, AIPs activate multiple proteases and small 
pore-forming toxins leading to biofilm disassembly (Oppenheimer-Shaanan et al., 
2013). AIPs and their derivatives are promising molecules in disrupting biofilms 
(Sakoulas, et al. 2003; Vuong et al., 2004). However, their specificity to certain 
bacterial strains may limit their activity. 
 
The second messenger nucleotides guanosine tetraphosphate (ppGpp) and guanosine 
pentaphosphate (pppGpp) (Figure 4) are also involved in biofilm formation in e.g., S. 
aureus (De la Fuente-Nunez et al., 2014). D-Enantiomeric peptides were reported to 
inhibit biofilm formation and disperse existing biofilms by degrading (p)ppGpp second 
messengers (De la Fuente-Nunez et al., 2015). The second messenger cyclic dimeric 
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guanosine monophosphate (c-di-GMP) is an intracellular signalling molecule that regulates 
the conversion of bacterial cells from the planktonic into the biofilm state and vice versa (Ha 
et al., 2015). Biofilm formation is associated with a high level of c-di-GMP, while a low level 
of c-di-GMP is associated with the higher motility of different bacterial species (Simm, et al., 
2004). Both second messengers, (p)ppGpp and (c-di-GMP), are involved in the regulation of 
biofilm formation and other functions such as virulence and quorum sensing (QS) (Gupta et 
al., 2015). The second messenger cyclic di-adenylate monophosphate (c-di-AMP) was 
recently reported to be involved in biofilm formation in certain bacterial species by increasing 
the production of the EPS (Peng et al., 2016; Townsley et al., 2018). 
 
 
Figure 4: Guanosine pentaphosphate (pppGpp). 
 
Amino acids. Amino acids are constituents of the peptidoglycans of Gram-positive 
cells, where a short peptide chain of amino acids is bound to the sugar polymer of the 
peptidoglycans. This peptide chain may play a role in cell-cell contact (Oppenheimer-
Shaanan et al., 2013). Amyloid fibres are aggregates of protein that attach to the 
bacterial cell wall and strengthen the structural integrity of B. subtilis biofilms 
(Romero et al., 2011). This attachment can be interrupted by introducing noncanonical 
D-amino acids that may not be a part of the peptidoglycan’s peptide chain amino acids 
leading to the prevention of biofilm maturation. Potentially this could disrupt 
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preformed biofilms in B. subtilis and prevent biofilm maturation in S. aureus 
(Hochbaum et al., 2011; Kolodkin-Gal et al., 2010). In contrast to these results of 
Kolodkin-Gal et al. (2010), recent studies show that D-amino acids do not inhibit 
biofilm formation in S. aureus or B. subtilis (Sarkar and Pires, 2015), but this may 
possibly be due to the different strains used in both studies. 
 
Polyamines. Polyamines are found in high concentrations in cells, concentrations 
which increase in rapidly growing cells (Tabor and Tabor, 1984). Linear polyamines 
incorporate 1,3-diaminopropane 1 and 1,4-diaminobutane 2 (putrescine). They play 
vital functions in almost all life including plants, mammals, and bacteria (Cohen, 1998; 
Oshima, 2010). Norspermidine 3 (caldine, 3.3) and norspermine 6 (thermine, 3.3.3) 
were first discovered in Thermus thermophilus as part of the many elegant studies in 
naturally occurring polyamines by Professor Oshima (Oshima, 1975, Oshima, 1978). 
T. thermophilus is an extreme thermophile, an aerobic Gram negative bacterium that 
lives at high temperatures 47-85º C with optimum temperature for growth between 65º 
C and 72ºC (Oshima and Imahori, 1971, 1974). Several linear polyamines have been 
isolated from T. thermophilus, including homospermidine 5, spermine 7, 
thermospermine 8, homospermine 9, caldopentamine 10, thermopent-amine 11, 
homocaldopentamine 12, caldohexamine 13, and homocaldohexamine 14 (Figure 5). 
They can stabilize double stranded DNA (dsDNA) at high temperatures which is vital 
for the thermophilic life of such bacteria (Oshima, 1975; Oshima, 1978; Oshima, 1979; 
Oshima, 1983; Oshima, 2010; Oshima et al., 1987; Oshima and Imahori, 1971, 1974). 
Spermidine 4, among other naturally occurring polyamines, works as a growth factor 
and regulates the synthesis of nucleic acids and proteins (Jansson et al., 2000; Yoshida 
et al., 2001). Longer and more complex polyamines can stabilize the structure of 















Figure 5: Polyamines isolated from T. thermophilus. The numbers after the polyamine names 






The activity of polyamines against biofilms varies among bacterial strains. Spermidine 
was reported to inhibit biofilm formation in Vibrio cholerae (Karatan et al., 2005). 
Norspermidine was required for biofilm formation in Vibrio cholerae (Burrell, et al., 
2010). These polyamines exert their different biological activities via multiple 
pathways including both QS and transport systems (Burrell et al., 2010; Karatan et al., 
2005; McGinnis et al., 2009). In contrast, norspermidine and norspermidine-
structurally related compounds (guanidine and biguanidine adducts) were reported to 
have a biofilm disrupting activity by preventing biofilm formation and dispersing 
existing biofilms in B. subtilis and S. aureus (Figure 6) (Bottcher et al., 2013; 
Oppenheimer-Shaanan et al., 2013), while spermidine or other polyamines were 
essential for biofilm formation in B. subtilis (Burrell et al., 2010). Recently, 
norspermidine was reported to have the ability to prevent biofilm formation in 
combination with copper ions (Lee et al., 2017). The exact mechanism of action of 
polyamines is still not fully understood. 
 
Figure 6: Certain polyamines, norspermidine and norspermine, have the ability to disperse 
existing biofilms liberating bacterial cells from within the biofilm matrix where they will be 
vulnerable to the body’s defences (the immune system) and also become accessible to 





Figure 7: Some naturally occurring polyamines. The two compounds on the left, 
norspermidine and norspermine, have the common motif of two adjacent three methylene 
groups separated and flanked by three amino groups. The two compounds on the right, 
spermidine and spermine, do not have this motif. 
 
The polyamines active against bacteria have a common component of two adjacent 
three methylene groups separated and flanked by three amino groups in their structure. 
Figure 7 shows the structure of four naturally occurring polyamines used in this study, 
where norspermidine (3.3) and norspermine (3.3.3) have a structural motif in common. 
Spermidine (3.4) and spermine (3.4.3) have an extra methylene group and so do not 
have the common motif in their structures. The numbers after the polyamine names 
indicate the number of methylene groups between the amino groups. 
 
A hypothesis was suggested by Kolodkin-Gal et al. (2012) to explain the structure-
activity relationship (SAR) of polyamines. However, it should be noted that this 
hypothesis was published in a Cell paper that has now been retracted. The authors of 
this paper claimed that norspermidine is biosynthesized by B. subtilis and is found in 
biofilms. In addition, they claimed that low concentrations of norspermidine inhibits 










It was also suggested by Kolodkin-Gal et al. that the positively charged amino groups 
of polyamines bind to negatively charged acidic (or neutral) groups of the 
exopolysaccharide, breaking hydrogen bonds between them and collapsing the 
exopolysaccharide network that holds the biofilm matrix together. Norspermidine 
(3.3) amino groups aligned well with the carboxyl groups of exopolysaccharide (or 
polar groups of neutral exopolysaccharide), while the spacing of the amino groups of 
spermidine (3.4) did not match the symmetric pattern. In contrast, another Cell paper 
reported that wild-type B. subtilis biofilms are norspermidine free throughout all the 
biofilm (Hobley et al., 2014). Moreover, the authors of this paper found that the 
activity of norspermidine depends on its concentration; at low concentrations up to 
200 µM it promotes biofilm formation, but at higher concentrations norspermidine 
prevents biofilm formation via an exopolysaccharide independent pathway. 
 
Kolodkin-Gal et al. also reported, in J. Am. Chem. Soc., that the activity of some 
polyamines and their guanidine (Figure 8) and biguanide adducts in inhibiting biofilm 
formation in S. aureus and B. subtilis generally increased at high protonation state in 
these compounds, while inactive compounds did not respond to changes in protonation 
(Bottcher et al., 2013). Indeed, both charge and the spacing between such positively 
charged functional groups affect biological activity. Understanding the SAR of 
polyamines will help to determine the active functional groups and the chemical 
structure of biologically active compounds, and thus the development of novel 






Norspermidine and a combination of norspermidine with silver ions were reported to 
disrupt and disinfect multispecies wastewater biofilms (Si et al., 2015; Wu et al., 
2016). Among two naturally occurring polyamines (norspermidine, spermidine) and 
the two diamines, putrescine (1,4-diaminobutane) and cadaverine (1,5-
diaminopentane), only norspermidine has the ability to inhibit biofilm formation in S. 
epidermidis (Ramon-Perez et al., 2015). However, not all polyamines are active 
against all bacterial strains, and those that are active demonstrate no clear mechanism 
of action. Some recent publications suggest that norspermidine acts by interfering with 
the QS process in bacteria (Cardile et al., 2017; Ou and Ling, 2017). 
 
Biofilm disruption makes the bacterial cells more vulnerable to antimicrobial agents, 
thereby potentially breathing new life into old drugs. These research studies will have 
impact and economic significance in many countries, especially if an understanding is 
developed of how polyamines and their conjugates or analogues could be used in order 
to overcome biofilm formation and disperse existing biofilms. This may also work in 
combination with antimicrobial agents as coatings of medical devices, in wastewater 
treatment, and in industries which use microorganisms. It is therefore important that 
new medicines are discovered and developed better to treat biofilm related infections. 
Polyamines and especially novel polyamines are compounds with potential in 
preventing and dispersing existing biofilms, because they can be active on several 
bacterial species and display their biological activity even at low (µM) concentrations. 
Alone or in combination with antibiotics, polyamines could have the advantage to 
eradicate many serious infections where biofilms are involved in mediating resistance. 
Therefore, the design and synthesis of some analogues of naturally occurring 




1.2 Aims and Objectives 
The aims of the research described in this thesis are to develop novel polyamines that 
can prevent biofilm formation and/or disrupt existing biofilms which will be of great 
importance for the treatment of bacterial infections. Such biofilm disruption will 
enhance the conventional activity of antibiotics against bacteria in pre-formed 
biofilms. A combination of antibiotics and polyamines together in a novel formulation 
could demonstrate exceptional synergistic activity in the therapy of bacterial 
infections. The mechanisms of action of polyamines against biofilms will also be 
investigated. 
 
These aims will be achieved by means of the following objectives:  
o Target polyamines will be synthesized by reacting selected natural polyamines 
with paraformaldehyde to form hexahydropyrimidines. These products will 
then be elongated with three carbons and amino groups by reacting with 
acrylonitrile followed by reduction of the nitrile groups to primary amines. 
o The activity of target products to prevent biofilm formation and disperse 
existing biofilms will be tested against three S. aureus strains using crystal 
violet and Miles-Misra assays. 
o The activity of target products to prevent biofilm formation and disperse 
existing biofilms in combination with the antibiotic vancomycin will be tested 
and assayed using confocal laser scanning microscopy. 
o The mechanisms of action will be investigated by testing the effects of micro-
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Medicinal chemistry of polyamines 
 
2.1 Introduction 
As highlighted in Chapter 1, polyamines can prevent biofilm formation and disperse 
existing biofilms in some bacterial strains. In order to design novel compounds, four 
naturally occurring polyamines, spermidine (4, 3.4), spermine (7, 3.4.3), norspermidine 
(3, 3.3), and norspermine (6, 3.3.3), were selected as starting materials. They vary in 
the number of amino groups and the distance between the amino groups. 
 
Figure 1: Homologous naturally occurring polyamines. 
Norspermine (thermine) 6 and norspermidine 3 have three methylene groups between 
each amino group. This will make the linear distance between each two amino groups 
three-carbon atoms as methylene groups. In comparison, spermine 7 and spermidine 4 
have an extra methylene group, which will increase the linear distance between some 
amino groups. Spermine 7 and norspermine 6 have four amino groups, but spermidine 
4 and norspermidine 3 have three amino groups in their chemical structures. This will 
therefore increase the number of positive charges that spermine and norspermine bear 
under the physiological range of pH likely to be present in biofilms (Figure 1). 
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2.2 Design and synthesis of analogues of naturally occurring polyamines 
Two factors were central in the polyamine compounds designed in this thesis:  the first 
was to add more amine groups, the second was making the charge spacing between 
certain amino groups, in an extended conformation, to be three methylenes. The 
difference between norspermidine and spermidine is an additional methylene group in 
the latter, and so spermidine potentially has a longer distance between amine groups, 
while norspermidine has a three methylene bridge between each two amine groups,. 
Spermine potentially has a longer distance between amine groups, while norspermine 
has a three methylene bridge between each two amine groups. However, spermidine 
can rearrange by free rotation of C-C bonds to have the same distance between the 
amino groups as found in norspermidine (Figure 2) although conformational analysis 
of these highly flexible linear polyamines is virtually unprecedented (Haworth et al., 
1991; Menger and D’Angelo, 1991; Maruyoshi et al., 2004). 
  
Figure 2: Spermidine can freely rotate (conformational isomerism) to have the same distance 
between the amino groups as is found in norspermidine. 
 
The second factor in the designed compounds was the number of amine groups. 
Additional positive charges on polyamines were reported to increase the activity of 
polyamines in preventing biofilm formation (Bottcher et al., 2013). The designed 
polyamines have additional amino groups with three methylene spacers between these 
amino groups which might give them more anti-biofilm activity. 
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Figure 3: Synthetic scheme of 33-36 from norspermidine 3, spermidine 4, norspermine 6 and 
spermine 7, respectively. Reagents and conditions:  (a) (i) H2O, cooling to 5°C, (ii) 
paraformaldehyde, 1 h; (b) (i) acrylonitrile, N2, anhydrous methanol, 15 h, (ii) acrylonitrile, 
N2, 9 h; (c) ethanol 95%, NaOH, H2 20 bar, Raney nickel, 20 h. 
 
The cyclic hexahydropyrimidine adducts 25-28 (Figure 3) were synthesised by the 
addition of solid paraformaldehyde to a cold aqueous solution of the starting polyamine 
(Ganem, 1982). This reaction is an example of a Mannich reaction where the formation 
of a Schiff base on one the primary amino groups is followed by a nucleophilic attack 
of another amino group on the formed Schiff base and the formation of a cycle. The 
reaction favours the formation of the stable six membered ring (Figure 4).  
 
 




The product of this reaction is obtained from the aqueous reaction mixture by 
thoroughly extracting with chloroform. However, the high polarity of such polyamine 
products often decreases the isolated yield. This low yield was overcome by saturating 
the reaction mixture with sodium hydroxide until an oily layer of the product appeared. 
The product layer was removed and the reaction mixture was thoroughly extracted with 
chloroform. This process increased the isolated yield up to 90% for compound 26. The 
yields for compounds 25-28 were 77%, 90%, 54%, and 81% respectively. 
 
The potential for free rotation about bonds in a linear polyamine chain prompted the 
design of conformationally restricted targets by incorporating two neighbouring amines 
into a hexahydropyrimidine. The addition of more amino groups separated by three 
methylene bridges to the hexahydropyrimidines was obtained by the 1,4-Michael 
addition of two equivalents of acrylonitrile to the hexahydropyrimidine adducts 25-28 
to form 29-32, respectively. This reaction did not always go to completion. Therefore, 
more acrylonitrile was added to the reaction mixture in order to achieve the desired 
products 29-32 having reacted with two equivalents of acrylonitrile. The yields for 
compounds 29-32 were 53%, 96%, 73%, and 86% respectively. None of these nitrile 
products has been previously reported except compound 29. The spectral data obtained 
for compound 29 are in agreement with those reported (Frydman et al., 2004) except 
that [M + H]+ is 250 not 249. Compound 29 has the chemical formula C13H23N5. So, 
the required mass for [M+H]+ which has the chemical formula C13H24N5 is equal to 
250.2032. Frydman et al. (2004) reported the mass for [M+H]+ = 249 for this 
compound. Our result shows the observed mass for [M+H]+ to be 250.2046 which is in 




In order to reduce nitrile compounds 29-32 to their corresponding target polyamines 
33-36 (Figure 3), several methods were tried. Firstly, catalytic hydrogenation using 
palladium. Palladium on carbon (Pd/C) is reported to reduce nitrile groups (Vilches-
Herrera et al., 2014). Catalytic hydrogenation using a hydrogen balloon as a hydrogen 
source and Pd/C (10%) as a catalyst in order to reduce compound 29 to 33 has been 
tried, but there was no reaction. TLC analysis showed a major spot of the starting 
material and several minor spots which could be from partial reduction. Replacing Pd/C 
with Pearlman’s catalyst (palladium hydroxide 20% on activated charcoal) gave the 
same result as the previous reaction. Increasing the hydrogen pressure to 20 bar resulted 
in a mixture of several products which could not be purified to homogeneity. 
 
A mild procedure to reduce nitrile groups to amines was reported using potassium 
borohydride (KBH4) as a reducing agent, Raney nickel as a catalyst and ethanol as a 
solvent (Wu et al., 2008). TLC analysis of the reaction following this procedure showed 
a major spot of the starting material and a few minor spots, possibly for partially 
reduced products. Lithium aluminium hydride (LiAlH4) has been reported to reduce 
some nitrile groups to primary amines (Bagal and Bhanage, 2015). Compound 29 was 
dissolved in anhydrous tetrahydrofuran and added dropwise to LiAlH4 in anhydrous 
tetrahydrofuran heated under reflux. After quenching with saturated aqueous Na2SO4 
and then neutralising with dilute sulfuric acid, the product was extracted with ether. In 
the experiments using LiAlH4, the starting material disappeared, but the product could 
not be extracted from the reaction mixture. Apparently, the amine product formed 
complexes with the metallic ions of lithium and / or aluminium in the reaction mixture. 
Another system has been published for reducing nitrile groups to primary amines by 
transfer hydrogenation using isopropanol as a hydrogen donor and a solvent and Raney 
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nickel as a catalyst (Mebane et al., 2003). Following this method, reactions showed the 
presence of a mixture of several products. 
 
In 2004, Frydman et al. reported that using ammonia as a co-catalyst with Raney nickel 
reduced the amount of secondary amine by-products in the reduction of nitriles to 
primary amines (Frydman et al., 2004). Following this procedure for compound 29 
resulted in a mixture of several products. In 1984, Bergeron and Garlich reported a 
method to reduce nitrile groups to primary amines using Raney nickel as a catalyst and 
sodium hydroxide as a co-catalyst under a hydrogen pressure of 2.7 bar (Bergeron and 
Garlich, 1984). Following this method at 20 bar of hydrogen pressure, the reaction was 
finally successful. Sodium hydroxide was dissolved in ethanol and added to compound 
29, Raney nickel was added to the mixture and the mixture was introduced into a Parr 
hydrogenator under 20 bar of hydrogen pressure for 20 h, the Parr hydrogenator was 
purged twice with hydrogen, the reduction afforded 33 in 45% yield. Repeating this 
reaction under 2.7 bar (Bergeron and Garlich, 1984) and even under 1 bar (Nazih et al., 
1999) of hydrogen pressure were also successful. It appeared that the use of sodium 
hydroxide as a co-catalyst was the key factor in the reduction of aliphatic nitrile groups 
to primary amines, at least in our hands. 
 
 
Figure 5: Synthetic scheme of 37 and 38 from norspermidine 3. 




Figure 6: Synthetic scheme of 39, 40 and 41 from norspermidine 3. 
Reagents and conditions: acrylonitrile (4 eq), N2, ethanol, 72 h. 
 
Compounds 37-41 (Figures 5 and 6) were designed to test the effect of branched 
polyamines compared to linear polyamines after reducing these nitrile adducts 37-41 
to their corresponding target amines. Compound 38 was formed as a by-product from 
the synthesis of its linear structural isomer 37. Both of them have the same chemical 
formula C12H24N5, which requires 238.2026 [M+H]
+, found 238.2079 for 37 and 
238.2033 for 38. They cannot be differentiated using mass spectrometry only. 
However, NMR spectroscopic analysis showed interesting results. Figure 7 shows the 
chemical shifts of carbon atoms for 37 and 38. Although the two compounds are 
isomers, 37 possesses a mirror plane of symmetry and therefore half of its carbons are 
equivalent to the other half. While in 38, all carbons have different chemical shifts, 






Figure 7: 13C NMR (125 MHz) chemical shifts of 37 and 38 in ppm. 
 
Figures 8 and 9 show the 13C-NMR spectra and assignment of both compounds 37 and 
38. The peak at 18.7 ppm in 37 represents the two equivalent carbons C-2 attached 
directly to nitrile groups, while in the spectrum of 38, there are two signals at 16.7 and 
18.8 ppm for C-13 and C-10, respectively. C-10 in 38 has a similar magnetic 
environment to the two equivalent carbons C-2 in 37 and has a similar chemical shift. 
C-13 in 38 is affected by the presence of one additional alkyl substitution at both γ- and 
δ-positions compared to C-10, which resulted in chemical shifts lower by a value of 
2.2 ppm than C-10. The calculated values of chemical shifts for C-10 and C-13 are in 
agreement with the observed value (Williams and Fleming, 2008). The peak at 30.0 
ppm in 37 is assigned to the equivalent carbons C-6, while in 38 there are two peaks at 
27.6 and 30.4 ppm and they are assigned to C-6 and C-2, respectively. C-6 in 38 is 
shielded by one more γ-alkyl substitution compared to C-2 and is expected to appear 
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in a more upfield position than C-2, so the peak at 27.5 ppm is assigned to C-6 and the 
peak at 30.3 ppm is assigned to C-2. The downfield low-intensity peak at 118.8 ppm in 
37 is assigned to the equivalent carbons C-1 de-shielded by the CN triple bond, while 
in 38 low-intensity peaks at 119.0 and 119.3 ppm are assigned to C-11 and C-14, 
respectively. These assignments follow because C-14 has one more δ-alkyl substitution 
compared to C-11 and is expected to appear in a more downfield position than C-11 by 
a value of 0.3 ppm (Williams and Fleming, 2008). So the peak at 119.0 ppm is assigned 
to C-11 and the peak at 119.3 ppm is assigned to C-14. However, other signals (45.1, 
47.8 and 48.4 in 37 and 45.3, 47.4, 48.6, 51.5 and 51.9 in 38) are α- to nitrogen with 
similar alkyl substitutions and can be less securely assigned due to their close chemical 









Figure 9: 13C-NMR (125 MHz) spectrum of compound 38. 
 
As an example of 1H NMR data, Figure 10 shows the chemical shifts of protons for 37 
and 38. Protons of C-2, C-3, C-5 and C-6 in 37 have similar magnetic environments to 
protons of C-10, C-9, C-7 and C-6 in 38 and have similar chemical shifts, while other 
protons in 38 are affected by the presence of the nitrile side-chain and the primary 
amine. 
 
Figure 10: 1H-NMR (500 MHz) chemical shifts of 37 and 38 in ppm. 
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Figures 11 and 12 show the 1H-NMR spectra and assignments of 37 and 38 
respectively. Protons were assigned according to matching with their corresponding 
13C signals depending on their HSQC-NMR spectrum (Figures 13 and 14). 
 





Figure 12: 1H-NMR (500 MHz) spectrum of compound 38. 
 




Figure 14: HSQC-NMR (500 MHz) spectrum of compound 38. 
 
Figure 15 shows the chemical shifts of carbon atoms for 39. This compound is 
symmetrical about the central tertiary nitrogen atom and its side-chain. 
 
 




Figure 16 shows the 13C-NMR spectrum and assignment of 39. The spectrum shows 9 
signals, the two downfield low intense signals at 119.3 and 119.0 ppm are assigned to 
C-11 and C-1 nitrile carbons, respectively. These assignments are based upon the 
relative intensities of the two signals, 119.0 ppm being significantly higher in intensity 
than that resonating at 119.3 ppm (Figure 17). The next 4 signals at 51.8, 49.6, 47.3 
and 45.2 ppm are assigned to NCH2 carbons C-7, C-9, C-5 and C-3 de-shielded by 
nitrogen. However, the assignment of these 4 signals is secured only for C-9 at 49.6 
ppm due to its lower relative intensity. The next 3 upfield signals at 27.5, 18.7 and 16.7 
ppm are assigned to carbons C-5, C-2 and C-10, respectively, in the same manner of 
the calculations used to assign the spectral data of 38. The peak at 16.7 ppm is assigned 
to C-10 due to its lower relative intensity compared to the peak at 18.7 ppm, and the 
effect of the presence of one additional alkyl substitution at γ- and δ-positions 
compared to the equivalent carbons C-2. So, the signal at 16.7 ppm is assigned to C-10 
and the signal at 18.7 ppm is assigned to C-2. 
 
Compound 39 has been previously synthesized (Balczewski et al., 2009) in order to 
make neurotoxins. The authors reported the spectral data for 39 but with one extra 
carbon signal. Compound 39 has 15 carbons and one point of symmetry in its chemical 
structure. Six (C-1, C-2, C-3, C-5, C-6, and C-7) have an equivalent six carbons, while 
three (C-9, C-10, and C-11) have no equivalent carbons (Figure 15). Therefore, its 13C 
NMR spectrum should show 9 signals. Balczewski et al. reported compound 39 with 






Figure 16: 13C-NMR (100 MHz) spectrum of compound 39. 
 




Figure 18: 13C NMR (125 MHz) chemical shifts of 40 in ppm. 
 
Figure 18 shows the chemical shifts of carbon atoms for 40. Carbons C-13, C-14 and 
C-15 are equivalent. Figures 19 to 22 show the 13C-NMR spectrum and its expansions 
leading to the assignment of 40. The spectrum shows 15 signals. The three downfield 
low intense signals at 119.5, 119.0 and 118.9 ppm are assigned to C-1, C-18 and C-15 
nitrile carbons, the assignment of these 4 signals is secured only for the equivalent C-
15 at 118.9 ppm due to its higher relative intensity (Figure 20). The next 7 signals at 
51.8, 51.2, 51.1, 49.5, 49.4, 47.3 and 45.1 ppm are assigned to NCH2 carbons C-9, C-
7, C-11, C-5, C-13, C-16 and C-3 de-shielded by nitrogen. However, the assignment of 
these 7 signals is secured only for the equivalent carbons C-13 at 49.5 ppm due to its 
higher relative intensity (Figure 21). The next two signals at 27.4 and 25.5 ppm are 
assigned to carbons C-6 and C-10, respectively. C-10 is affected by the presence of one 
additional alkyl substitution at γ- and δ-positions compared to C-6 which resulted in a 
chemical shift lower than C-6. The next 3 upfield signals at 18.8, 17.0 and 16.8 ppm 
are assigned to carbons C-2, C-14 and C-17. C-2 is affected by the presence of one less 
alkyl substitution at γ- and δ-positions compared to C-14 and C-17 which resulted in a 
chemical shift lower than C-14 and C-17, so the signal at 18.8 ppm is assigned to C-2. 
The signal at 17.0 ppm is assigned to the two equivalent carbons C-14 due to its higher 





Figure 19: 13C-NMR (125 MHz) spectrum of compound 40. 
 




Figure 21: Expanded 13C-NMR (125 MHz) spectrum of compound 40. 
 




Figure 23: 13C NMR (125 MHz) chemical shift of 41 in ppm. 
Figure 23 shows the chemical shifts of carbon atoms in 41. This compound is 
symmetrical about the central nitrogen N-8 and also about the two N-4 nitrogens. 
Figures 24 to 26 show the 13C-NMR spectrum and assignments of 41. The spectrum 
shows 9 signals, the two downfield low intense signals at 119.7 and 119.0 ppm are 
assigned to C-11 and C-1 nitrile carbons. The signal at 119.7 ppm is assigned to C-11 
and the signal at 119.0 ppm is assigned to four equivalent carbons C-1 due to its higher 
relative intensity. The next four signals resonating at 51.3, 51.2, 49.6 and 49.3 ppm are 
assigned to NCH2 carbons C-7, C-5, C-3 and C-9 de-shielded by nitrogen. C-5 and C-
7 have the same α-, β- and γ-substitution, but C-5 is affected by the presence of one δ-
alkyl and two δ-CN substitution, while C-7 is affected by the presence of three δ-alkyl 
and one δ-CN substitution, which makes the calculated chemical shift for C-5 to be 1.1 
ppm lower than C-7, so the peak at 51.3 ppm is assigned to the two equivalent carbons 
C-5, the peak at 51.2 ppm is assigned to the two equivalent carbons C-7. However, due 
to the close chemical shift for these carbons, it is not secure enough to depend on this 
low difference for assignment. The signal at 49.6 ppm is assigned to the four equivalent 
carbons C-3 due to its higher relative intensity, while the signal at 49.3 ppm is assigned 
to C-9 due to its lower relative intensity (Figure 25). The peak at 25.4 ppm is assigned 
to the two equivalent carbons C-6. The next peak at 17.0 ppm is assigned to the four 
equivalent carbons C-2 due to its higher relative intensity, while the peak at 16.9 ppm 




Figure 24: 13C-NMR (125 MHz) spectrum of compounds 41. 
 




Figure 26: Expanded 13C-NMR (125 MHz) spectrum of compound 41. 
 
The purpose of designing compounds 37-41 was to reduce these nitrile adducts to their 
corresponding branched polyamines and compare their activity against bacterial 
biofilms with linear polyamines. However, the reduction of these compounds following 
the procedure mentioned above for the reduction of compound 29 was not successful. 
The products could not be extracted from the reaction mixture. Most likely, the high 
polarity of the products made it hard to extract these products from the aqueous sodium 
hydroxide solution. Compounds 33-36 were successfully obtained following this 
procedure by the reduction of compounds 29-32, respectively. The presence of 
hexahydropyrimidine rings in compounds 33-36 slightly decreased their polarity, 
compared with free linear polyamines, enough to be extracted from the aqueous sodium 




Whilst these experiments were underway, a paper published by Hoque and co-workers 
(Hoque et al., 2016) showed the activity of diamino-diamide-substituted molecules to 
prevent biofilm formation and even to eradicate established biofilms. Some of their 
bactericidal molecules share a common structural feature having a hydrocarbon chain 
flanked by positively charged moieties, quaternised amines, as illustrated (Figure 27): 
 
  
Figure 27: Cationic molecules which are both antibacterial and antibiofilm in their activities. 
 
Their most active molecules 64-67 (Figure 34) are discussed in more detail  in Chapter 
3. They contain a hydrocarbon chain of 6- to 12-methylene spacers between amine 
groups. By varying the length of the hydrophobic spacers between the ammonium 
positive charges, they synthesised cationic molecules that demonstrated both 
antibacterial and antibiofilm activity with low toxicity. Studying the SAR of these 
active compounds prompted the design of molecules 46-49 (Figure 28). Compounds 
46-49 are therefore expected to have biological activity against biofilms as they have 
two amine functional groups (ammonium ions) separated by methylene bridges of 7, 8, 
10, and 12 carbons and flanked by another three methylenes each terminating in 









Figure 28: Synthetic scheme of 46-49. 
Reagents and conditions:  (a) (i) acrylonitrile, N2, anhydrous methanol, 15 h, (ii) acrylonitrile, 




Compounds 46-49 were synthesized by the addition of two equivalents of acrylonitrile 
to the starting materials to produce 42-45 respectively, followed by the reduction of 
nitrile groups to primary amines. Compounds 37-45 (Figure 28) have been reported 
(Balczewski et al., 2009; Frydman et al., 2004; Jahromi et al., 2013; Klenke et al., 2001; 
Liew et al., 2013; Pearce et al., 2017; Sharma et al., 2010), but either without spectral 
data or the spectral data were not fully assigned. Therefore, the spectral data were fully 
assigned for these compounds supported by the calculated values of their chemical 
shifts. Proton signals were assigned according to their carbon connectivities in the 
corresponding HSQC-NMR spectra. Figures 29-36 show the assigned 13C, 1H and 
HSQC-NMR spectra for compounds 42-45 supported by the calculated values 
compared to the observed ones (Tables 1-9). The calculations are made using the 13C 
equation and the associated data tables in Williams and Fleming (2008): 
δC = -2.3 + Ʃz + ƩS + ƩK  
where -2.3 ppm is the 13C chemical shift for methane (ppm), z is the substituent 
constant, S is a “steric” correction, and K is a conformational increment for -
substituents. 
 
Figure 29 shows the chemical shifts of proton and carbon atoms for 42, this molecule 
is symmetrical around C-8.  
 
 




Figures 30 to 32 show the 13C, 1H and HSQC-NMR spectrum and assignment of 42. 
The 13C-NMR spectrum (Figure 32) shows 7 signals, the downfield low intense signal 
at 118.9 ppm are assigned to C-1 nitrile carbons. The next 2 signals at 49.3 and 45.2 
ppm are assigned to NCH2 carbons C-5, C-3, respectively de-shielded by nitrogen. The 
next 3 signals at 30.0, 29.4 and 27.2 ppm are assigned to carbons C-6, C-8 and C-7, 
respectively. The signal at 29.4 is assigned to carbon C-8 due to its lower relative 
intensity only occurring once in this symmetrical molecule 42. The upfield peak at 18.8 
ppm is assigned to C-2. 
 
 




Figure 31: 1H-NMR (500 MHz) spectrum of compound 42. 
 
Figure 32: HSQC-NMR spectrum of compound 42. 
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Figure 33 shows the chemical shifts of all the carbon and proton atoms in 43. 
 
 
Figure 33: 13C-NMR (upper) and 1H-NMR (lower) chemical shifts of 43 in ppm. 
 
Figures 34 to 36 show the 13C, 1H and HSQC-NMR spectrum and assignment of 43. 
The 13C-NMR spectrum (Figure 34) shows 7 signals, the downfield low intense signal 
at 118.9 ppm is assigned to C-1 nitrile carbons. The next 2 signals at 49.3 and 45.2 ppm 
are assigned to NCH2 carbons C-5 and C-3, respectively, deshielded by nitrogen. The 
next 3 signals at 30.1, 29.5 and 27.2 ppm are assigned to carbons C-6, C-8 and C-7, 
respectively. The signal at 29.5 is assigned to carbons C-8 which have higher relative 
intensity compared to C-8 in compound 42, as it represents two equivalent carbons in 
43 while it represents only one carbon in 42. The upfield peak at 18.8 ppm is assigned 
to C-2. Compound 43 has been previously synthesized (Liew et al., 2013) in order to 
make antimalarial polyamines. The authors reported the spectral data for compound 43. 
It appears that using DMSO-d6 as the solvent, they mistakenly swapped the assignment 
of the carbon signals for methylene groups at 14.4 and 42.0 ppm to C-3 and C-2, 
respectively (Liew et al., 2013), but these have been corrected in this thesis. 
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Here, carbon signals at 18.8 and 45.2 ppm were assigned to C-2 and C-3, respectively 
(Figure 34). C-3 is α-position to amino group and should appear in an upfield region, 
while C-2 is α-position to nitrile group and β-position to amino group. Nitrile group 
have low effect on de-shielding adjacent carbons and increase their chemical shift only 
by 3.1 ppm, therefore, C-2 should appear in a downfield region. The calculated value 
for C-2 and C-3 signals are 19.0 and 44.7 ppm, respectively (Williams and Fleming, 
2008). Our results are in agreement with the calculated values. We performed our 
experiment in CDCl3 solvent. To overcome the effect on NMR signals that may derived 
from using a different solvent, the NMR measurements were made using DMSO-d6 
where C-2 and C-3 appeared at 17.8 and 44.9 ppm respectively, in agreement with our 
CDCl3 and calculated values (Table 7). 
 
 





Figure 35: 1H-NMR (500 MHz) spectrum of compound 43. 
 




Figure 37: 13C-NMR (Left) and 1H-NMR (right) chemical shifts of 44 in ppm. 
 
Figure 37 shows the chemical shifts of proton and carbon atoms in 44. Figures 38 to 40 
show the 13C, 1H and HSQC-NMR spectrum and assignment of 44. The 13C-NMR 
spectrum (Figure 38) shows 7 signals, the downfield low intensity signal at 118.9 ppm 
is assigned to both C-1 nitrile carbons. The next 2 signals at 49.4 and 45.2 ppm are 
assigned to NCH2 carbons C-5 and C-3, respectively, de-shielded by nitrogen. The next 
3 signals at 30.1, 29.6 and 27.3 ppm are assigned to carbons C-6, C-8 and C-9, and C-
7, respectively. The signal at 29.6 is assigned to two carbons, C-8 and C-9, due to its 
higher relative intensity. The upfield peak at 18.9 ppm is assigned to C-2. 
 




Figure 39: 1H-NMR (500 MHz) spectrum of compound 44. 
 





Figure 41: 13C-NMR (upper) and 1H-NMR (lower) chemical shifts of 45 in ppm. 
 
Figure 41 shows the chemical shifts of the proton and carbon atoms in 45. 
 
Figures 42 to 44 show the 13C, 1H and HSQC-NMR spectrum and assignment of 45. 
The 13C-NMR spectrum (Figure 42) shows 9 signals, the downfield low intense signal 
at 118.9 ppm is assigned to C-1 nitrile carbons. The next 2 signals at 49.4 and 45.2 ppm 
are assigned to NCH2 carbons C-5 and C-3, respectively, de-shielded by nitrogen. The 
next 5 signals at 30.2, 29.7, 29.7, 29.6 and 27.3 ppm are assigned to carbons C-6, C-8, 










Figure 43: 1H-NMR (500 MHz) spectrum of compound 45. 
 
Figure 44: HSQC-NMR spectrum of compound 45. 
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As discussed above, all the polyamine conjugate spectral data were fully assigned for 
these compounds supported by the calculated values of their chemical shifts. Tables 1-
9 show the calculated 13C-NMR chemical shifts for compounds 37-45 using the 
equation given by Williams and Fleming (2008); the observed values are all in 
agreement with the calculated values. These are significant data as is often the case 
with phytochemistry and the spectroscopic analysis of natural products where the 
unambiguous assignment allows the correct chemical structure to be confirmed. 
 






α-CN β-N γ-alkyl δ-alkyl   Total Observed 
C2 -2.3 9.1 3.1 11.3 -2.5 0.3   19.0 18.7 
  α-
alkyl 
α-N β-alkyl β-CN γ-alkyl δ-alkyl    
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α-alkyl α-N β-alkyl γ-N δ-alkyl  Total Observed 
C1 -2.3 9.1 28.3 9.4 -5.1 0.6  40.0 40.1 
  2α-
alkyl 
2β-N 2γ-alkyl 2δ-alkyl     
C2 -2.3 18.2 22.6 -5 0.6   34.1 30.3 
  α-alkyl α-N 3β-alkyl γ-N 2γ-alkyl δ-alkyl   
C3 -2.3 9.1 28.3 28.2 -5.1 -5 0.3 53.5 51.4 
  α-alkyl α-N 3β-alkyl γ-N 2γ-alkyl 2δ-alkyl   
C5 -2.3 9.1 28.3 28.2 -5.1 -5 0.6 53.8 51.8 
  2α-
alkyl 
2β-N 3γ-alkyl 2δ -alkyl     
C6 -2.3 18.2 22.6 -7.5 0.9   31.9 27.4 
  α-alkyl α-N 2β-alkyl γ-N γ-alkyl 2δ-alkyl   
C7 -2.3 9.1 28.3 18.8 -5.1 -2.5 0.6 46.9 47.3 
  α-alkyl α-N β-alkyl β-CN γ-alkyl δ-alkyl   
C9 -2.3 9.1 28.3 9.4 2.4 -2.5 0.3 44.7 45.2 
  α-alkyl α-CN β-N γ-alkyl δ-alkyl    
C10 -2.3 9.1 3.1 11.3 -2.5 0.3  19.0 18.7 
  α-alkyl α-N 2β-alkyl β-CN 2γ-alkyl 2δ-alkyl   
C12 -2.3 9.1 28.3 18.8 2.4 -5 0.6 51.9 49.5 
  α-alkyl α-CN β-N 2γ-alkyl 2δ-alkyl    








α-alkyl α-CN β-N γ-alkyl δ-alkyl   Total Observed 
C2 -2.3 9.1 3.1 11.3 -2.5 0.3   19.0 18.6 
  α-alkyl α-N β-alkyl β-CN γ-alkyl δ-alkyl    
C3 -2.3 9.1 28.3 9.4 2.4 -2.5 0.3  44.7 45.1 




   







     
C6 -2.3 18.2 22.6 -7.5 0.9    31.9 27.4 






S   
C7 -2.3 9.1 28.3 28.2 -5.1 -5 0.6 -2.5 51.3 51.7 
           






   
C9 -2.3 9.1 28.3 18.8 2.4 -5 0.6 -2.5 47.0 49.5 
  α-alkyl α-CN β-N 2γ-
alkyl 
δ-alkyl     















δ-alkyl   Total Observed 
C2 -2.3 9.1 3.1 11.3 -2.5 0.3   19.0 18.7 
  α-alkyl α-N β-alkyl β-CN γ-alkyl δ-alkyl    
C3 -2.3 9.1 28.3 9.4 2.4 -2.5 0.3  44.7 45.1 




   







     
C6 -2.3 18.2 22.6 -7.5 0.9    31.9 27.3 






S   
C7 -2.3 9.1 28.3 28.2 -5.1 -5 0.6 -2.5 51.3 51.2 






S   







     
10 -2.3 18.2 22.6 -10 1.2    29.7 25.4 
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S   
C11 -2.3 9.1 28.3 28.2 -5.1 -5 0.6 -2.5 51.3 51.8 




δ-alkyl S   
C13 -2.3 9.1 28.3 18.4 2.4 -5 0.3 -2.5 49.1 49.5 






    
C14 -2.3 9.1 3.1 11.3 -5 0.6   16.8 16.9 






   
C16 -2.3 9.1 28.3 18.8 2.4 -5 0.6 -2.5 47.0 47.3 




δ-alkyl     
C17 -2.3 9.1 3.1 11.3 -5 0.6   16.8 16.8 
 
 








  Total Observed 
C2 -2.3 9.1 3.1 11.3 -5 0.6   16.8 17.0 




δ-alkyl S   
C3 -2.3 9.1 28.3 18.8 2.4 -5 0.3 -2.5 49.1 49.6 
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S   







     
C6 -2.3 18.2 22.6 -10 1.2    29.7 25.4 






S   
C7 -2.3 9.1 28.3 28.2 -5.1 -5 0.9 -2.5 51.6 51.2 






   
C9 -2.3 9.1 28.3 18.8 2.4 -5 0.6 -2.5 47.0 49.3 
  α-alkyl α-CN β-N 2γ-
alkyl 
δ-alkyl     
C10 -2.3 9.1 3.1 11.3 -5 0.6   16.8 16.9 
 
 




α-alkyl α-CN β-N γ-alkyl δ-alkyl  Total Observed 
C2 -2.3 9.1 3.1 11.3 -2.5 0.3  19.0 18.8 
  α-alkyl α-N β-alkyl β-CN γ-alkyl δ-alkyl   
C3 -2.3 9.1 28.3 9.4 2.4 -2.5 0.3 44.7 45.2 







C5 -2.3 9.1 28.3 18.8 2.4 -5 0.6 48.7 49.3 
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C6 -2.3 9.1, 9.1 11.3 9.4 -5 0.6  32.2 30.0 




   







     
C8 -2.3 18.2 18.8 -5    29.7 29.4 
 
 




α-alkyl α-CN β-N γ-alkyl δ-alkyl  Total Observed 
C2 -2.3 9.1 3.1 11.3 -2.5 0.3  19.0 18.8 
  α-alkyl α-N β-alkyl β-CN γ-alkyl δ-alkyl   
C3 -2.3 9.1 28.3 9.4 2.4 -2.5 0.3 44.7 45.2 














   





γ- N γ-alkyl 2δ-
alkyl 
   









δ-alkyl     
C8 -2.3 18.2 18.8 -5 0.3   30.0 29.5 
 
 




α-alkyl α-CN β-N γ-alkyl δ-alkyl  Total Observed 
C2 -2.3 9.1 3.1 11.3 -2.5 0.3  19.0 18.9 
  α-alkyl α-N β-alkyl β-CN γ-alkyl δ-alkyl   
C3 -2.3 9.1 28.3 9.4 2.4 -2.5 0.3 44.7 45.2 














   







   







δ-alkyl     







δ-alkyl     








α-alkyl α-CN β-N γ-alkyl δ-alkyl  Total Observed 
C2 -2.3 9.1 3.1 11.3 -2.5 0.3  19.0 18.9 
  α-alkyl α-N β-alkyl β-CN γ-alkyl δ-alkyl   
C3 -2.3 9.1 28.3 9.4 2.4 -2.5 0.3 44.7 45.2 














   
C6 -2.3 18.2 11.3 9.4 -5 0.6  32.2 30.2 




   







δ-alkyl     







δ-alkyl     







δ-alkyl     







Norspermidine, norspermine, spermidine, spermine, paraformaldehyde, acrylonitrile, 
and Raney nickel were purchased from Sigma-Aldrich. Anhydrous sodium sulfate and 
Celite were purchased from Fisher Scientific. Anhydrous methanol, methanol, ethanol, 
acetone, chloroform, dichloromethane, ethyl acetate, and ammonia were purchased 
from VWR. CDCl3, DMSO-d6 and deuterium oxide were purchased from Goss 
Scientific. All chemicals and solvents were used in reactions directly as obtained, 
without further purification. 
 
Thin-Layer Chromatography (TLC) was carried out on aluminium-backed silica gel 
F254 plates 20 x 20 cm purchased from Merck (Darmstadt, Germany). Reaction 
mixtures and products were separated using the following mobile phases:  CHCl3: 
EtOH: NH4OH (5:10:12, v/v/v); CHCl3: EtOH: NH4OH (5:5:1, v/v/v); CHCl3: EtOH: 
NH4OH (7:3:1, v/v/v); CH2Cl2: EtOH: EtOAc: NH4OH (3:3:3:0.5, v/v/v/v). After 
drying, the TLC eluted chromatograms were developed by spraying with Dragendorff’s 
reagent which was prepared by mixing two solutions A and B. Solution A contains 
bismuth nitrate (0.17 g) in glacial acetic acid (2 mL) and H2O (8 mL). Solution B 
contains KI (4 g) in glacial acetic acid (10 mL) and H2O (20 mL). Solutions A and B 
were mixed and then diluted to 100 mL with H2O (Bisen, 2014). An alternative TLC 
spray reagent for amines is ninhydrin reagent (0.2 g of ninhydrin in 100 mL ethanol). 
Column chromatography was performed on silica gel 60-120 mesh (purchased from 
Sigma-Aldrich) using different ratios of ethanol, methanol, chloroform, and 





NMR spectroscopic analysis (1H, 13C, and HSQC) was carried out by dissolving 
samples (about 15 mg) in CDCl3, DMSO-d6 or D2O (0.6 mL). IR spectroscopic analysis 
used a Perkin-Elmer 65 FT-IR spectrometer with solid samples prepared as KBr discs 
and liquid samples examined as thin films on NaCl plates. High Resolution Time-of-
Flight (HR TOF) mass spectra were obtained on a Bruker Daltonics “micrOTOF” mass 
spectrometer using positive-ion mode electrospray ionisation (ESI). 
 
General procedure for analogue synthesis. 
Compounds 25-28 were prepared as previously described by the Blagbrough research 
group (Ashton et al., 1995) with the exception that paraformaldehyde was used instead 
of formalin. Briefly, each polyamine (1 g each of spermidine, spermine, norspermidine, 
or norspermine) was dissolved in water (30 mL). The aqueous solution was then cooled 
to 5 °C and paraformaldehyde (1 or 2 eq. depending upon the starting material) was 
added. The mixture was stirred for 1 h at 20 °C and then thoroughly extracted with 
chloroform (8 x), dried (Na2SO4), filtered and the solvent was then removed under 
reduced pressure. Compounds (29-32 and 37-41) were synthesized as previously 
described (Frydman et al., 2004) with the exception that anhydrous methanol was used 
instead of ethanol. The formaldehyde adducts were dissolved in anhydrous methanol 
followed by the dropwise addition of acrylonitrile with stirring under N2. After 15 h, 
more acrylonitrile was added because not all of the starting material was reacted (TLC 
analysis) and stirring was continued for a further 9 h. The resulting mixture was then 
concentrated under reduced pressure. Compounds 33-36 and 46-49 were prepared as 
previously described (Bergeron and Garlich, 1984). Products were purified to 
homogeneity by column chromatography, and characterised by HR-MS, IR, and 1H, 
13C and HSQC NMR spectroscopy. 
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2.4.1 Synthesis of 3-(hexahydropyrimidin-1(2H)-yl)propan-1-amine (25). 
 
Method A: this compound was prepared as previously described (Ashton et al., 1995) 
except that solid paraformaldehyde was used instead of aqueous formalin solution. To 
norspermidine 3 (1.00 g, 7.62 mmol) in distilled water (30 mL), cooled to 5 °C, was 
added paraformaldehyde (0.229 g, 7.62 mmol, 1 eq.). After stirring for 1 h at 20 °C the 
resulting mixture was then thoroughly extracted with chloroform (8 x 10 mL). The 
combined organic extracts were dried (Na2SO4), filtered and the solvent was removed 
under reduced pressure to give a colourless oil (0.280 g, 26%). 
IR: 3303 (NH), 2938, 2805 (CH2) cm
-1; 
HRMS: found 144.1477, C7H18N3 requires 144.1495 [M+H]
+; 
1H NMR (400 MHz; CDCl3): 1.48-1.56 (m, 4 H, 2CH2), 1.78 (br s, 3 H, NH and NH2), 
2.20 (t, J = 7.6 Hz, 2 H, NCH2), 2.47 (br s, 2 H, NCH2), 2.64 (t, J = 6.8 Hz, 2 H, NCH2), 
2.71 (t, J = 5.6 Hz, 2H, NCH2), 3.28 (s, 2 H, NCH2N); 
13C NMR (100 MHz; CDCl3): 27.0, 30.4 (CH2), 40.6, 45.1, 53.0, 53.1 (NCH2), 69.9 
(NCH2N). 
The spectral data are in agreement with those reported (Houen et al., 2005). 
The above reaction was repeated under different conditions to increase the yield. 
 
Method B: to norspermidine (1.00 g, 7.62 mmol) in methanol (15 mL, 0.01M NaOH) 
cooled to 5 °C was added paraformaldehyde (0.229 g, 7.62 mmol, 1 eq.). After stirring 
for 1 h at 20 °C the TLC analysis showed several spots. 
To norspermidine (10.00 g, 76.2 mmol) in distilled water (60 mL) cooled to 5 °C was 
added paraformaldehyde (2.29 g, 76.2 mmol, 1 eq.). After stirring for 1 h at 20 °C, TLC 
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analysis showed one spot (Rf = 0.4, ethanol: CHCl3: NH4OH, 5: 5: 1 v/v/v). Sodium 
hydroxide pellets were added until a second layer appeared. The organic layer was 
removed and dissolved in chloroform. The aqueous layer was thoroughly extracted 
with chloroform (8 x 10 mL). The combined chloroform fractions were dried (Na2SO4), 
filtered and the solvent was removed under reduced pressure to give a colourless oil 
(8.39 g, 77%) that was used in the next step without further purification. 
 
2.4.2 Synthesis 4-(hexahydropyrimidin-1(2H)-yl)butan-1-amine (26). 
 
Method A: this compound was prepared by the same procedure as described for 25. To 
spermidine (1.00 g, 6.89 mmol) in distilled water (30 mL), cooled to 5 °C, 
paraformaldehyde (0.207 g, 6.89 mmol, 1 eq.) was added. After stirring for 1 h at 20 
°C, the resulting mixture was thoroughly extracted with chloroform (8 x 10 mL). The 
combined chloroform fractions were dried (Na2SO4), filtered and the solvent was 
removed under reduced pressure to give a colourless oil (0.65 g, 60%). 
IR: 3343 (NH), 2940 and 2861 (CH2) cm
-1; 
HRMS: Found 158.1645, C8H19N4 requires 158.1652 [M+H]
+; 
1H NMR (400 MHz): 1.37-1.55 (m, 4 H, 2CH2), 1.57 (quin, J = 5.5 Hz, 2 H, CH2), 
2.19-2.22 (m, 2 H, NCH2), 2.53 (br s, 2 H, NCH2), 2.66 (t, J = 6.4 Hz, 2 H, NCH2), 
2.77 (t, J = 5.5 Hz, 2 H, NCH2), 3.34 (s, 2 H, NCH2N); 
13C NMR (100 MHz): 24.2, 27.0, 31.7 (CH2), 41.9, 45.1, 53.0, 55.3 (NCH2), 69.8 
(NCH2N). 
The spectral data are in agreement with those reported (Siddiqui et al., 1999). 
The above reaction was repeated with different conditions to increase the yield. 
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Method B: to spermidine (5.00 g, 34.4 mmol) in distilled water (75 mL) cooled to 5 °C 
was added paraformaldehyde (1.083 g, 36.1 mmol, 1.05 eq.). After stirring for 1 h at 
20 °C the TLC analysis showed one spot (Rf = 0.3, ethanol: CHCl3: NH4OH, 5: 5: 1 
v/v/v). Sodium hydroxide pellets were added until a second layer appeared. The upper 
organic layer was removed and dissolved in chloroform. The aqueous layer was 
thoroughly extracted with chloroform (8 x 10 mL). The combined chloroform fractions 
were dried (Na2SO4), filtered and the solvent was removed under reduced pressure to 
give a colourless oil (4.90 g, 90%). 
 
2.4.3 Synthesis of 1,3-bis(hexahydropyrimidin-1(2H)-yl)propane (27). 
 
This compound was prepared following the same procedure described for 25. To 
norspermine (1.00 g, 5.31 mmol) in distilled water (30 mL) cooled to 5 °C was added 
paraformaldehyde (0.318 g, 10.62 mmol, 2 eq.). After stirring for 1 h at 20 °C, the 
resulting mixture was then thoroughly extracted with chloroform (8 x 10 mL). The 
combined chloroform fractions were dried (Na2SO4), filtered and the solvent was 
removed under reduced pressure to give a colourless oil (0.61 g, 54%). 
IR: 3263 (NH), 2937 and 2793 (CH2) cm
-1; 
HRMS: Found 213.2100, C11H25N4 requires 213.2074 [M+H]
+; 
1H NMR (400 MHz): 1.55-1.66 (m, 8 H, 3CH2, 2NH), 2.23 (t, J = 7.6 Hz, 4 H, 2NCH2), 
2.54 (br s, 4 H, 2NCH2), 2.78 (t, J = 6.0 Hz, 4 H, 2NCH2), 3.35 (s, 4 H, 2NCH2N) 
13C NMR: (100 MHz): 24.3, 27.1 (3 x CH2), 45.2, 53.1, 53.6 (6 x NCH2), 70.0 (2 x 
NCH2N). 
This compound has not been previously reported. 
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2.4.4 Synthesis 1,4-bis(hexahydropyrimidin-1(2H)-yl)butane (28). 
 
Method A: to spermine (1.00 g, 4.94 mmol) in distilled water (30 mL), cooled to 5 °C, 
was added paraformaldehyde (0.297 g, 9.88 mmol, 2 eq.) After stirring for 1 h at 20 
°C, the resulting mixture was then thoroughly extracted with chloroform (8 x 10 mL). 
The combined chloroform fractions were dried (Na2SO4), filtered and the solvent was 
removed under reduced pressure to give a colourless oil (0.38 g, 34%). 
IR: 3348 (NH), 2934 (CH2) cm
-1; 
HRMS: Found 227.2273, C12H27N4 requires 227.2230 [M + H]
+; 
1H NMR (400 MHz): 1.41-1.50 (m, 4 H, 2CH2), 1.55-1.65 (m, 6 H, 2NH and 2CH2), 
2.21 (br s, 4 H, 2NCH2), 2.53 (br s, 4 H, 2NCH2), 2.78 (t, J = 6.0 Hz, 4 H, 2NCH2), 
3.34 (s, 4 H, 2NCH2N); 
13C NMR (100 MHz): 25.0, 27.2 (4 x CH2), 45.2, 53.1, 55.4 (6 x NCH2), 70.0 (2 x 
NCH2N). 
This compound was previously reported, but without any spectral data (Ganem, 1982). 
Method B: the above reaction was repeated with different conditions in order to 
increase the yield. To spermine (5.00 g, 24.7 mmol) in distilled water (75 mL), cooled 
to 5 °C, was added paraformaldehyde (1.558 g, 51.9 mmol, 2.05 eq.). After stirring for 
1 h at 20 °C the TLC analysis showed one spot (Rf = 0.6, ethanol: CHCl3: NH4OH, 5: 
5: 1 v/v/v). Sodium hydroxide pellets were added until a second layer appeared. The 
upper organic layer was removed and dissolved in chloroform. The aqueous layer was 
thoroughly extracted with chloroform (8 x 10 mL). The combined chloroform fractions 
were dried (Na2SO4), filtered and the solvent was removed under reduced pressure to 
give a colourless oil (4.50 g, 81%). 
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2.4.5 Synthesis of 3-(3-(3-((2-cyanoethyl)amino)propyl)hexahydropyrimidin-1(2H)-
yl)propanenitrile (29). 
 
This compound was prepared as previously described (Frydman et al., 2004) with the 
exception that anhydrous methanol was used instead of ethanol. To 25 (1.00 g, 6.98 
mmol) in anhydrous methanol (15 mL) was added acrylonitrile (0.91 mL, d = 0.81 
g/mL, 0.741 g, 13.96 mmol, 2 eq.) and the solution was stirred at 20 °C under N2 for 
15 h. TLC analysis showed that the reaction had not gone to completion by the presence 
of two spots (Rf = 0.1, 0.6, ethanol: ethyl acetate: CH2Cl2: NH4OH, 3: 3: 3: 0.5 v/v/v/v). 
Therefore, an excess of acrylonitrile (0.46 mL, d = 0.81 g/mL, 0.37 g, 6.98 mmol, 1 
equivalent) was added and stirring continued for a further 7 h and then the excess of 
acrylonitrile and the solvent were removed under reduced pressure to give a colourless 
oil (1.18 g, 53%). 
IR: 3306, (NH), 2940 and 2818 (CH2), 2249 (CN) cm
-1; 
HRMS: Found 250.2046, C13H24N5 requires 250.2032 [M+H]
+; 
1H NMR (400 MHz; CDCl3): 1.55-1.63 (m, 4 H), 2.34 (t, J = 7.2 Hz, 2 H), 2.42-2.47 
(m, 6 H), 2.53-2.56 (m, 2 H), 2.61 (t, J = 6.8 Hz, 2 H), 2.69 (t, J = 6.8 Hz, 2 H), 2.84 
(t, J = 6.4 Hz, 2 H) (10 CH2), 3.15 (s, 2 H, NCH2N). 
13C NMR (100 MHz; CDCl3): 16.6, 18.5, 22.7, 27.0 (4 x CH2), 45.0, 47.6, 50.0, 51.8, 
52.3, 53.0 (6 x CH2), 75.2 (NCH2N), 118.8, 118.9 (2 x CN).  
The spectral data are in agreement with those reported (Frydman et al., 2004) except 




2.4.6 Synthesis of 3-(3-(4-((2-cyanoethyl)amino)butyl)hexahydropyrimidin-1(2H)-yl)-
propanenitrile (30).  
 
Method A: this compound was prepared by the same procedure as described for 29. To 
26 (1.00 g, 6.36 mmol) in anhydrous methanol (15 mL) was added acrylonitrile (0.84 
mL, d = 0.81 g/mL, 0.68 g, 12.72 mmol, 2 eq.) and the solution was stirred at 20 °C 
under N2 for 15 h. TLC analysis showed that the reaction had not gone to completion 
by the presence of two spots (Rf = 0.1, 0.7, ethanol: ethyl acetate: CH2Cl2: NH4OH, 3: 
3: 3: 0.5 v/v/v/v). Therefore, an excess of acrylonitrile (0.42 mL, d = 0.81 g/mL, 0.34 
g, 6.36 mmol, 1 equivalent) was added and stirring continued for a further 7 h and then 
the excess of acrylonitrile and the solvent were removed under reduced pressure to give 
a colourless oil (1.61 g, 96%).  
IR: 3352 (NH), 2937 and 2815 (CH2), 2247 (CN) cm
-1; 
HRMS: Found 264.2190, C14H26N5 requires 264.2183 [M + H]
+; 
1H NMR (400 MHz): 1.37-1.50 (m, 4 H), 1.58-1.63 (m, 2 H), 2.24-2.31 (m, 2 H), 2.39-
2.47 (m, 6 H), 2.51-2.61 (m, 4 H), 2.69 (t, J = 7.2 Hz, 2 H), 2.85 (t, J = 6.8 Hz, 2 H) 
(11 CH2), 3.15 (s, 2 H, NCH2N); 
13C NMR (100 MHz): 16.6, 18.7, 22.8, 24.8, 27.9 (5 x CH2), 45.0, 48.9, 50.1, 51.9, 
52.2, 54.7 (6 x NCH2), 75.4 (NCH2N), 118.6, 118.8 (2 x CN). 
This compound has not been previously reported. 
 
Method B: the above reaction was repeated with different conditions in order to 
increase the scale. 
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To 4-(hexahydropyrimidin-1(2H)-yl)butan-1-amine (4.9 g, 31.2 mmol) in anhydrous 
methanol (25 mL) was added acrylonitrile (4.1 mL, d = 0.81 g/mL, 3.32 g, 62.6 mmol, 
2 eq.) dissolved in methanol (15 mL) dropwise over 10 min, and the solution was stirred 
at 20 °C under N2 for 15 h. TLC analysis showed the presence of two spots (Rf = 0.1, 
0.7, ethanol: ethyl acetate: CH2Cl2: NH4OH, 3: 3: 3: 0.5 v/v/v/v). However the NMR 
analysis showed high purity, the second spot was only a minor impurity. The excess of 
acrylonitrile and the solvent were removed under reduced pressure to give a colourless 
oil (7.847 g, 96%). 
 
2.4.7 Synthesis of 3,3'-(propane-1,3-diylbis(hexahydropyrimidine-3,1(2H)-diyl))-di-
propanenitrile (31).  
 
This compound was prepared using the same procedure as described for 29. To 27 (1.00 
g, 4.71 mmol) in anhydrous methanol (15 mL) was added acrylonitrile (0.62 mL, d = 
0.81 g/mL, 0.450 g, 9.42 mmol, 2 eq.) and the solution was stirred at 20 °C under N2 
for 15 h. TLC analysis showed that the reaction had not gone to completion by the 
presence of two spots (Rf = 0.1, 0.8, ethanol: ethyl acetate: CH2Cl2: NH4OH, 3: 3: 3: 
0.5 v/v/v/v). Therefore, an excess of acrylonitrile (0.31 mL, d = 0.81 g/mL, 0.225 g, 
4.71 mmol, 1 equivalent) was added and stirring continued for a further 7 h and then 
the excess of acrylonitrile and the solvent were removed under reduced pressure to give 
a pale yellow liquid (1.4 g), which was subjected to chromatography over silica gel 
column and eluted with CH2Cl2: methanol: NH4OH (85: 14: 1 v/v/v) to give a clear 
yellow oil (1.09 g, 73%). This compound has not been previously reported. 
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IR: 3371 (NH), 2941and 2805 (CH2), 2249 (CN) cm
-1; 
HRMS: Found 319.2644, C17H31N6 requires 319.2605 [M + H]
+; 
1H NMR (400 MHz): 1.53-1.65 (m, 6 H), 2.31 (t, J = 7.2 Hz, 4 H), 2.40-2.46 (m, 8 H), 
2.55 (t, J = 5.2 Hz, 4 H), 2.70 (t, J = 6.8 Hz, 4 H), (13 CH2), 3.15 (s, 4 H, NCH2N); 
13C NMR (100 MHz): 16.6, 22.8, 24.8 (5 x CH2), 50.1, 51.9, 52.2, 52.9 (8 x NCH2), 
75.4 (2 x NCH2N), 118.8 (2 x CN). 
 
2.4.8 Synthesis of 3,3'-(butane-1,4-diylbis(hexahydropyrimidine-3,1(2H)-diyl))-di-
propanenitrile (32). 
 
Method A: this compound was prepared using the same procedure as described for 29. 
To 28 (1.00 g, 4.42 mmol) in anhydrous methanol (15 mL) was added acrylonitrile 
(0.58 mL, d = 0.81 g/mL, 0.47 g, 8.84 mmol, 2 eq.) and the solution was stirred at 20 
°C under N2 for 15 h. TLC analysis showed that the reaction had not gone to completion 
by the presence of two spots (Rf = 0.1, 0.8, ethanol: ethyl acetate: CH2Cl2: NH4OH, 3: 
3: 3: 0.5 v/v/v/v). Therefore, an excess of acrylonitrile (0.29 mL, d = 0.81 g/mL, 0.24 
g, 4.42 mmol, 1 equivalent) was added and stirring continued for a further 7 h, and then 
the excess of acrylonitrile and the solvent were removed under reduced pressure to give 
a colourless oil (1.26 g, 86%). 
IR: 3371 (NH), 3939, 2859 (CH2), 2244 (CN) cm
-1; 
HRMS: Found 333.2809, C18H33N6 requires 333.2761 [M+H]
+; 
1H NMR (400 MHz): 1.38-1.46 (m, 2 H), 1.57-1.65 (m, 2 H), 2.23-2.30 (m, 2 H), 2.40-
2.47 (m, 4 H), 2.50-2.85 (m, 2 H), 2.67-2.73 (m, 2 H) (7 CH2), 3.14 (s, 2 H, NCH2N); 
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13C NMR (100 MHz): 16.6, 22.8, 25.1 (6 x CH2), 50.1, 51.9, 52.2, 54.9 (8 x CH2), 75.4 
(2 x NCH2N), 118.8 (2 x CN). This compound has not been previously reported. 
 
Method B: the above reaction was repeated with different conditions on a larger scale. 
To 1,4-bis(hexahydropyrimidin-1(2H)-yl)butane (2.673 g, 11.81 mmol) in methanol 
(25 mL) was added acrylonitrile (1.55 mL, d = 0.81 g/mL, 1.25 g, 23.62 mmol, 2 eq.) 
dropwise over 1 h, and the solution was stirred at 20 °C under N2 for 2 h. TLC analysis 
showed that the reaction had not gone to completion by the presence of two spots (Rf 
= 0.1, 0.8, ethanol: ethyl acetate: CH2Cl2: NH4OH, 3: 3: 3: 0.5 v/v/v/v). Therefore, an 
excess of acrylonitrile (1 mL, d = 0.81 g/mL, 0.81 g, 15.26 mmol, 1.3 eq.) was added 
and stirring continued for 15 h under N2 and then the excess of acrylonitrile and the 
solvent were removed under reduced pressure to give a colourless oil (3.378 g, 86%). 
 
2.4.9 Synthesis of N1-(3-(3-(3-aminopropyl)hexahydropyrimidin-1(2H)-
yl)propyl)propane-1,3-diamine (33).  
 
Method A: LiAlH4 (1.22 g, 32.1 mmol, 4 eq) was dissolved in anhydrous 
tetrahydrofuran (20 mL) and heated under reflux. Compound 29 (2.00 g, 8.02 mmol) 
was dissolved in  tetrahydrofuran (50 mL) and added dropwise slowly, under nitrogen, 
to the mixture without affecting the reflux. The reaction was heated under reflux for 10 
minutes then cooled to 20 °C. Saturated aqueous Na2SO4 solution was cautiously added 
to the reaction mixture, then quenched with 10% aqueous sulfuric acid (95 mL). The 
reaction mixture was then extracted with ether (3 x 30 mL). The combined organic 
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fractions were dried (Na2SO4), filtered and the solvent was removed under reduced 
pressure. TLC analysis showed that the starting material disappeared, but the product 
could not be extracted from the reaction mixture. Apparently, the amine product formed 
complexes with the metallic ions of lithium and/or aluminium in the reaction mixture. 
 
Method B: this compound was prepared as previously described (Bergeron and Garlich, 
1984). Compound 29 (2.00 g, 8.02 mmol) was dissolved in anhydrous ethanol (50 mL) 
that was previously saturated with ammonia gas and introduced into a Parr 
hydrogenator. Raney nickel (~ 3 g) was activated by heating in NaOH solution (6 M) 
for 90 minutes, 60 °C and washed 6 times with anhydrous ethanol (20 mL) and was 
added to the Parr hydrogenator. The Parr hydrogenator was purged twice with H2 and 
the reaction was carried out at room temperature for 2 h at H2 pressure of 50 bar. After 
2 h, the pressure did not fall down suggesting that the hydrogen was not consumed and 
the reaction had not finished, so the reaction left for another 15 h. After 15 h, the 
pressure did not fall down so the temperature was elevated to 60 °C at H2 pressure of 
50 bar. After 6 h the pressure fell down to lower than 20 bar suggesting that either the 
reaction had finished or the hydrogen was leaking. The reaction mixture was filtered 
through Celite with ethanol, the residue was washed with ethanol (2 x 5 mL) and the 
combined filtrates were removed under reduced pressure. The resulting mixture was 
then thoroughly extracted with a mixture of chloroform: methanol (85: 15 v/v, 8 x 10 
mL). The combined organic fractions were dried (Na2SO4), filtered and the solvent was 
removed under reduced pressure to give colourless oil. However, TLC analysis showed 
that the reaction had not gone to completion by the presence of several spots (ethanol: 
NH4OH, 2: 1 v/v). 




1H NMR analysis showed overlapped and broad peaks that could not be assigned. 
13C NMR analysis showed the disappearance of nitrile signals at 118.7 and 118.8 and 
the appearance of several new peaks in the aliphatic carbons region. 
The above reaction was therefore attempted under different conditions. 
 
Method C: the compound 29 (2.00 g, 8.02 mmol) was added to a solution of sodium 
hydroxide (0.74 g, 18.50 mmol) in 95% ethanol (15 mL). Raney nickel (~ 0.3 g) was 
added to the mixture and introduced into a Parr hydrogenator. The Parr hydrogenator 
was purged twice with H2 and the reaction was carried out at 30 °C for 20 h at H2 
pressure of 20 bar. After 20 h the pressure fell down to lower than 5 bar suggesting 
that the hydrogen was consumed. The reaction mixture was filtered through Celite 
with ethanol and the filtrate was removed under reduced pressure. The resulting 
mixture was then thoroughly extracted with a mixture of chloroform: methanol (85: 
15 v/v, 8 x 10 mL). The combined organic fractions were dried (Na2SO4), filtered and 
the solvent was removed under reduced pressure to give a pale yellow oil (0.920 g, 
45%). TLC analysis showed a major spot (Rf = 0.1, ethanol: NH4OH, 2: 1 v/v). 
IR: 3280, (NH), 2930, 2858 (CH2) cm
-1; 
HRMS: Found 258.2658, C13H32N5 requires 258.2652 [M+H]
+; 
1H NMR (500 MHz): 1.45-1.61 (m, 8 H, 4CH2), 2.26-2.35 (m, 4 H, 2NCH2), 2.38-2.54 
(m, 12 H, 6NCH2), 3.1 (s, 2 H, NCH2N); 
13C NMR (125 MHz): 21.2, 25.7, 28.9, 31.6 (4 x CH2), 38.6, 39.0, 46.2, 46.8, 51.9, 
52.2 (6 x NCH2), 51.4 (2 x NCH2), 73.1 (NCH2N). 
This compound has not been previously reported. 
 





This compound was prepared by the same procedure described for 34. The nitrile 
compound 30 (1.00 g, 3.80 mmol) was added to a solution of sodium hydroxide (0.74 
g, 18.50 mmol) in 95% ethanol (15 mL). Raney nickel (~ 0.3 g) was added to the 
mixture and introduced into a Parr hydrogenator. The Parr hydrogenator was purged 
twice with H2 and the reaction was carried out at 30 °C for 20 h at H2 pressure of 20 
bar. After 20 h the pressure fell down to lower than 5 bar suggesting that the 
hydrogen was consumed. The reaction mixture was centrifuged and the supernatant 
liquid was filtered through Celite and the filtrate was removed under reduced 
pressure. The resulting mixture was then thoroughly extracted with a mixture of 
chloroform: methanol (85: 15 v/v, 8 x 10 mL). The combined organic fractions were 
dried (Na2SO4), filtered and the solvent was removed under reduced pressure to give 
a pale yellow oil (0.815 g, 79%). TLC analysis showed a major spot (Rf = 0.1, 
ethanol: NH4OH, 2: 1 v/v).  
IR: 3329, (NH), 2930, 2858 (CH2) cm
-1; 
HRMS: Found 272.2832, C14H33N5 requires 272.2809 [M+H]
+; 
1H NMR (500 MHz): 1.41-1.53 (m, 4 H, 2CH2), 1.57-1.68 (m, 6 H, 3CH2), 2.26-2.39 
(m, 4H, 2NCH2), 2.40-2.50 (m, 4 H, 2NCH2), 2.54-2.60 (m, 2 H, NCH2), 2.63 (t, J = 
7.0 Hz, 2 H, NCH2), 2.67-2.77 (m, 4 H, 2NCH2), 3.08 (s, 2 H, NCH2N); 
13C NMR (125 MHz): 23.8, 25.2, 28.3, 31.0, 34.0 (5 x CH2), 40.5, 40.6, 47.9, 50.1, 
52.6, 52.7, 53.2, 55.4 (8 x NCH2), 76.8 (NCH2N). 
This compound has not been previously reported. 
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2.4.11 Synthesis of 3,3'-(propane-1,3-diylbis(hexahydropyrimidine-3,1(2H)-diyl))bis-
(propan-1-amine) (35).  
 
Following the procedure described for 35. The nitrile compound 20 (1.00 g, 3.14 mmol) 
was added to a solution of sodium hydroxide (0.74 g, 18.50 mmol) in 95% ethanol (15 
mL). Raney nickel (~ 0.3 g) was added to the mixture and introduced into a Parr 
hydrogenator. The Parr hydrogenator was purged twice with H2 and the reaction was 
carried out at 30 °C for 20 h at H2 pressure of 20 bar. After 20 h, the pressure fell down 
to lower than 5 bar suggesting that the hydrogen was consumed. The reaction mixture 
was centrifuged and the supernatant liquid was filtered through Celite using ethanol 
and the filtrate was removed under reduced pressure. The resulting mixture was then 
thoroughly extracted with a mixture of chloroform: methanol (85: 15 v/v, 8 x 10 mL). 
The combined organic fractions were dried (Na2SO4), filtered and the solvent was 
removed under reduced pressure to give a pale yellow oil (0.313 g, 30%). TLC analysis 
showed a major spot (Rf = 0.3, ethanol: NH4OH, 2: 1 v/v). 
IR: 3329 (NH), 2941, 2790 (CH2) cm
-1; 
HRMS: Found 327.3252, C17H38N6 requires 327.3231 [M+H]
+; 
1H NMR (500 MHz): 1.54-1.69 (m, 12 H, 6CH2), 2.29-2.38 (m, 8 H, 4NCH2), 2.39-
2.51 (m, 8 H, 4NCH2), 2.7 (t, J = 7.0 Hz, 4 H, 2NCH2), 3.06 (s, 4 H, 2NCH2N); 
13C NMR (125 MHz): 23.8 (2 x CH2), 25.1 (CH2), 31.0 (2 x CH2), 40.6, 52.6, 52.7, 
53.2, 53.6 (10 x NCH2), 76.7 (2 x NCH2N). 




2.4.12 Synthesis of 3,3'-(butane-1,4-diylbis(hexahydropyrimidine-3,1(2H)-diyl))-bis-
(propan-1-amine) (36).  
 
Following the procedure described for 33, nitrile 32 (1.00 g, 3.01 mmol) was added to 
a solution of sodium hydroxide (0.74 g, 18.50 mmol) in 95% ethanol (15 mL). Raney 
nickel (~ 0.3 g) was added to the mixture and introduced into a Parr hydrogenator. The 
Parr hydrogenator was purged twice with H2 and the reaction was carried out at 30 °C 
for 20 h at H2 pressure of 20 bar. After 20 h, the pressure fell down to lower than 5 bar 
suggesting that the hydrogen was consumed. The reaction mixture was filtered through 
Celite and the filtrate was removed under reduced pressure. The resulting mixture was 
then thoroughly extracted with a mixture of chloroform: methanol (85: 15 v/v, 8 x 10 
mL). The combined organic fractions were dried (Na2SO4), filtered and the solvent was 
removed under reduced pressure to give a white solid (0.487 g, 48%). TLC analysis 
showed a major spot (Rf = 0.3, ethanol: NH4OH, 2: 1 v/v). 
IR: 3354, (NH), 2940 and 2799 (CH2) cm
-1; 
HRMS: Found 341.3403, C18H41N6 requires 341.3387 [M+H]
+; 
1H NMR (500 MHz): 1.34-1.38 (m, 4 H, 2CH2), 1.47-1.57 (m, 8 H, 4CH2), 2.16-2.23 
(m, 4 H, 2NCH2), 2.26 (t, J = 7.0 Hz, 4 H, 2NCH2), 2.28-2.43 (m, 8 H, 4NCH2), 2.62 
(t, J = 7.0 Hz, 4 H, 2NCH2), 2.97 (s, 4 H, 2NCH2N); 
13C NMR (125 MHz): 23.5 (2 x CH2), 25.2 (2 x CH2), 30.8 (2 x CH2), 40.6, 52.4, 52.5, 
52.9, 55.2 (10 x NCH2), 76.5 (2 x NCH2N). 
This compound has not been previously reported. 
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2.4.13 Synthesis of 3,3'-((azanediylbis(propane-3,1-diyl))bis(azanediyl)-)dipropane-
nitrile (37).  
 
This compound was prepared as previously described (Frydman et al., 2004). To 
norspermidine (2.00 g, 15.24 mmol) in ethanol (20 mL) was added acrylonitrile (2 mL, 
d = 0.81 g/mL, 1.60 g, 30.48 mmol, 2 eq.) and the solution was stirred at 20 °C under 
N2 for 24 h. TLC analysis showed the presence of two close spots (Rf = 0.4, 0.4, 
ethanol: ethyl acetate: CH2Cl2: NH4OH, 3: 3: 3: 0.5 v/v/v/v). Then the solution was 
removed under reduced pressure to give a clear pale yellow liquid (3.6 g) which was 
subjected to chromatography over silica gel column and eluted with methanol: CH2Cl2: 
NH4OH (14: 85: 1 v/v/v) to give a clear yellow oil 37 (0.4 g, 11%) and a clear pale 
yellow oil 38 (0.2 g, 6%). 
 
IR: 3308 (NH), 2947 and 2832 (CH2), 2248 (CN); 
HRMS: Found 238.2079, C12H24N5 requires 238.2026 [M + H]
+; 
1H NMR (500 MHz): 1.61 (q, J = 6.8 Hz, 4 H, H-6), 2.46 (t, J = 6.8 Hz, 4 H, H-2), 
2.59-2.68 (m, 8 H, H-5, H-7), 2.85 (t, J = 6.4 Hz, 2 H, H-3); 
13C NMR (100 MHz): 18.7 (2x C-2), 30.0 (2x C-6), 45.1, 47.8, 48.4 (2x C-3, 2x C-5, 
2x C-7), 118.8 (2x C-1).  




2.4.14 Synthesis of 3-((3-((3-aminopropyl)(2-cyanoethyl)amino)propyl)amino)-
propanenitrile (38).  
 
IR: 3300 (NH), 2937 and 2828 (CH2), 2246 (CN); 
HRMS: Found 238.2033, C12H24N5 requires 238.2026 [M+H]
+; 
1H NMR (500 MHz; CDCl3): 1.61-1.68 (m, 4 H, H-2, H-7), 2.48-2.56 (m, 8 H, H-3, H-
5. H-10, H-13), 2.66-2.78 (m, 6 H, H-1, H-7, H-12), 2.89 (t, J = 7.0 Hz, 2 H, H-9); 
13C NMR (125 MHz; CDCl3): 16.7 (C-13), 18.8 (C-10), 27.6 (C-6), 30.4 (C-2), 40.1 
(C-1), 45.3 (C-9), 47.4 (C-7), 49.6 (C-12), 51.5(C-3), 51.9 (C-5), 119.0 (C-11), 119.3 
(C-14). 
This compound has been reported, but without spectral data (Balczewski et al., 2009) 
 
2.4.15 Synthesis of 3,3'-((((2-cyanoethyl)azanediyl)bis(propane-3,1-diyl))bis-
(azanediyl))dipropanenitrile (39).  
 
This compound was prepared as previously described (Frydman et al., 2004). To 
norspermidine (2.00 g, 15.24 mmol) in ethanol (20 mL) was added acrylonitrile (4 mL, 
d = 0.81 g/mL, 3.2 g, 60.96 mmol, 4 eq.) and the solution was stirred at 20 °C under 
N2 for 72 h. TLC analysis showed the presence of several spots. Then the solution was 
removed under reduced pressure to give a clear yellow liquid which was subjected to 
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chromatography over silica gel column and eluted with two mobile phases (CH2Cl2: 
methanol: NH4OH, 95: 4.75: 0.25 v/v/v) and (CH2Cl2: methanol: NH4OH, 90: 9.5: 0.5 
v/v/v) to give a clear yellow oil 39 (0.64 g, 15%), a clear yellow oil 40 (0.975 g, 19%) 
and a clear yellow oil 41 (0.24 g, 4%). 
IR: 3299, (NH), 2939, 2831 (CH2), 2247 (CN) cm
-1; 
HRMS: Found 291.2300, C15H27N6 requires 291.2292 [M+H]
+; 
1H NMR (500 MHz): 1.61-1.68 (m, 4 H, H-6, 2NH), 2.45-2.56 (m, 10 H, 2x H-2, 2x 
H-7, H-10), 2.69-2.76 (m, 6 H, 2 x H-5, H-9), 2.92 (t, J = 7.0 Hz, 4 H, 2 x H-3); 
13C NMR (125 MHz): 16.7 (C-10), 18.7 (2 x C-2), 27.5 (2 x C-6), 45.1 (2 x C-3), 47.3 
(2 x C-5), 49.6 (C-9), 51.8 (2 x C-7), 119.0 (2 x C-1), 119.3 (C-11). 
The spectral data are in good agreement with those reported (Balczewski et al., 2009) 
with the exception that they reported an extra carbon in the NMR 13C data. This issue 
is discussed in the results section of compound 39 (Figure 16). 
 
2.4.16 Synthesis of 3,3'-((3-((2-cyanoethyl)(3-((2-cyanoethyl)amino)propyl)amino)-
propyl)azanediyl)dipropanenitrile (40).  
 
IR: 3340, (NH), 2943, 2830 (CH2), 2247 (CN) cm
-1; 




1H NMR (500 MHz; CDCl3): 1.61-1.68 (m, 4 H, C-6, C-10), 2.48-2.56 (m, 12 H, H-2, 
H-7, H-11, 2x H-14, H-17), 2.62 (t, J = 7.0 Hz, 2 H, H-9), 2.69-2.76 (m, 4 H, H-5, H-
16), 2.86 (t, J = 6.5 Hz, 4 H, 2x H-13), 2.92 (t, J = 6.5 Hz, 2 H, H-3); 
13C NMR (125 MHz; CDCl3): 16.8 (C-17), 17.0 (2x C-14), 18.8 (C-2), 25.5 (C-10), 
27.4 (C-6), 45.2 (C-3), 47.4 (C-16), 49.5 (C-5), 49.6 (2x C-13), 51.2 (C-9), 51.3 (C-7), 
51.9 (C-11), 118.9 (2x C-15), 119.1 (C-18), 119.5 (C-1). 
This compound has not been previously reported. 
 
2.4.17 Synthesis of 3,3'-((3-((2-cyanoethyl)(3-((2-cyanoethyl)(2-isocyanoethyl)-
amino)propyl)amino)propyl)-azanediyl)dipropanenitrile (41).  
 
IR: 3620, (NH), 2945, 2833 (CH2), 2247 (CN) cm
-1; 
HRMS: Found 397.2861, C21H33N8 requires 397.2823 [M+H]
+; 
1H NMR (400 MHz): 1.64 (q, J = 7.0 Hz, 4 H, 2x H-6), 2.47-2.53 (m, 10 H, 4x H-2, 
H-10), 2.55 (t, J = 7.0 Hz, 4 H, 2 x H-5), 2.62 (t, J = 7.0 Hz, 4 H, 2x H-7), 2.74 (t, J = 
6.5 Hz, 2 H, H-9), 2.86 (t, J = 7.0 Hz, 8 H, 4 x H-3); 
13C NMR (100 MHz): 16.9 (C-10), 17.0 (4 x C-2), 25.4 (2 x C-6), 49.3 (C-9), 49.6 (4 
x C-3), 51.2 (2 x C-5), 51.3 (2 x C-7), 119.0 (4 x C-1), 119.7 (C-11).  






2.4.18 Synthesis of 3,3'-(heptane-1,7-diylbis(azanediyl))dipropanenitrile (42).  
 
To heptane-1,7-diamine (1.00 g, 8.68 mmol) in ethanol (30 mL) was added acrylonitrile 
(1 mL, d = 0.81 g/mL, 0.815 g, 15.35 mmol, 2 eq.) dropwise and the solution was 
stirred at 20 °C under N2 for 15 h. TLC analysis showed that the reaction had not gone 
to completion by the presence of two spots (Rf = 0.1, 0.5, ethanol: ethyl acetate: 
CH2Cl2: NH4OH, 3: 3: 3: 0.5 v/v/v/v). Therefore, an excess of acrylonitrile (0.25 mL, 
d = 0.81 g/mL, 0.225 g, 3.8 mmol, 0.4 equivalent) was added and stirring continued for 
a further 7 h and then the excess acrylonitrile and the solvent were removed under 
reduced pressure to give a colourless liquid in quantitative yield. This compound has 
been previously reported (Sharma et al., 2010). 
IR: 3312 (NH), 2929 and 2855 (CH2), 2248 (CN) cm
-1; 
HRMS: Found 237.2109, C13H25N4 requires 237.2074 [M+H]
+; 
1H NMR (500 MHz; CDCl3): 1-1.2 (br, 2 H) (NH), 1.25-1.34 (m, 6 H, H-7, H-8), 
1.45 (q, J = 7.0 Hz, J = 7.0 Hz, 4 H, H-6), 2.49 (t, J = 7.0 Hz, 4 H, H-2), 2.59 (t, J = 
7.0 Hz, 4 H, H-5), 2.89 (t, J = 7.0 Hz, 4 H, H-3); 
13C NMR (125 MHz; CDCl3): 18.8 (2 x C-2), 27.2 (2 x C-7), 29.4 (C-8), 30.0 (2 x C-
6), 45.2 (2 x C-3), 49.3 (2 x C-5). 118.9 (2 x C-1). 
 




This compound was prepared as previously described for 29. To 1,8-octanediamine 
(1.00 g, 6.93 mmol) in ethanol (30 mL) was added acrylonitrile (0.91 mL, d = 0.81 
g/mL, 0.74 g, 13.86 mmol, 2 eq.) dropwise and the solution was stirred at 20 °C under 
N2 for 15 h. TLC analysis showed that the reaction had not gone to completion by the 
presence of two spots (Rf = 0.1, 0.6, ethanol: ethyl acetate: CH2Cl2: NH4OH, 3: 3: 3: 
0.5 v/v/v/v). Therefore, an excess of acrylonitrile (0.2 mL, d = 0.81 g/mL, 0.162 g, 2.7 
mmol, 0.4 equivalent) was added and stirring continued for 7 h and then the excess of 
acrylonitrile and the solvent were removed under reduced pressure to give a white solid 
in quantitative yield. The spectral data are in agreement with those previously reported 
(Jahromi et al., 2013; Liew et al., 2013). 
IR: 3312 (NH), 2925 and 2853 (CH2), 2248 (CN) cm
-1; 
HRMS: Found 251.2262, C14H27N4 requires 251.2230 [M+H]
+; 
1H NMR (500 MHz; CDCl3): 1.11 (br, 2 H, 2 x NH), 1.25-1.34 (m, 8 H, H-7, H-8), 
1.46 (q, J = 7.0 Hz, J = 7.0 Hz, 4 H, H-6), 2.50 (t, J = 7.0 Hz, 4 H, H-2), 2.60 (t, J = 
7.0 Hz, 4 H, H-5), 2.90 (t, 4 H, J = 7.0 Hz, H-3); 
13C NMR (125 MHz; CDCl3): 18.8 (C-2), 27.2 (C-7), 29.5 (C-8), 30.1 (C-6), 45.2 (C-
3), 49.3 (C-5). 118.9 (C-1). 
 
2.4.20 Synthesis of 3,3'-(decane-1,10-diylbis(azanediyl))dipropanenitrile (44).  
 
This compound was prepared as previously described for 29. To decane-1,10-diamine 
(1.00 g, 5.80 mmol) in ethanol (30 mL) was added acrylonitrile (0.76 mL, d = 0.81 
g/mL, 0.616 g, 11.61 mmol, 2 eq.) dropwise and the solution was stirred at 20 °C under 
N2 for 15 h. TLC analysis showed that the reaction had not gone to completion by the 
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presence of two spots (Rf = 0.1, 0.6, ethanol: ethyl acetate: CH2Cl2: NH4OH, 3: 3: 3: 
0.5 v/v/v/v). Therefore, an excess of acrylonitrile (0.2 mL, d = 0.81 g/mL, 0.162 g, 2.7 
mmol, 0.5 equivalent) was added and stirring continued for a further 7 h and then the 
excess acrylonitrile and the solvent were removed under reduced pressure to give a 
white solid in quantitative yield. The spectral data are in agreement with those 
previously reported (Pearce et al., 2017). 
IR: 3314 (NH), 2921 and 2847 (CH2), 2248 (CN) cm
-1; 
HRMS: Found 279.2560, C16H31N4 requires 279.2543 [M+H]
+; 
1H NMR (500 MHz; CDCl3): 1.13 (br, 2 H) (NH), 1.24-1.34 (m, 12 H, H-7, H-8, H-
9), 1.47 (q, J = 7.0 Hz, J = 7.0 Hz, 4 H, H-6), 2.51 (t, J = 7.0 Hz, 4 H, H-2), 2.62 (t, J 
= 7.0 Hz, 4 H, H-5), 2.92 (t, J = 7.0 Hz, 4 H, H-3); 
13C NMR (125 MHz; CDCl3): 18.9 (C-2), 27.3 (C-7), 29.6 (C-8), 29.6 (C-9), 30.1 (C-
6), 45.2 (C-3), 49.4 (C-5). 118.9 (C-1). 
 
2.4.21 Synthesis of 3-(12-[(2-cyanoethyl)amino]dodecylamino)propanenitrile (45).  
 
This compound was prepared as previously described for 29. To 1,12-diaminododecane 
(1.00 g, 4.99 mmol) in ethanol (30 mL) was added acrylonitrile (0.65 mL, d = 0.81 
g/mL, 0.53 g, 9.98 mmol, 2 eq.) dropwise and the solution was stirred at 20 °C under 
N2 for 15 h. TLC analysis showed that the reaction had not gone to completion by the 
presence of two spots (Rf = 0.1, 0.7, ethanol: ethyl acetate: CH2Cl2: NH4OH, 3: 3: 3: 
0.5 v/v/v/v). Therefore, an excess of acrylonitrile (0.2 mL, d = 0.81 g/mL, 0.162 g, 2.7 
mmol, 1 equivalent) was added and stirring continued for 7 h and then the excess 
acrylonitrile and the solvent were removed under reduced pressure to give a white solid 
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in quantitative yield. The spectral data are in agreement with those previously reported 
(Klenke et al., 2001). 
IR: 3289 (NH), 2919 and 2851 (CH2), 2260 (CN) cm
-1; 
HRMS: Found 307.2791, C16H31N4 requires 307.2856 [M+H]
+; 
1H-NMR (500 MHz; CDCl3): 1.14 (br, 2 H, NH), 1.22-1.33 (m, 16 H, H-7, H-8, H-9, 
H-10), 1.47 (q, J = 7.0 Hz, 4 H, H-6), 2.51 (t, J = 7.0 Hz, 4 H, H-2), 2.61 (t, J = 7.0 
Hz, 4 H, H-5), 2.92 (t, J = 6.5 Hz, 4 H, H-3); 
13C-NMR (125 MHz; CDCl3): 18.9 (C-2), 27.3 (C-7), 29.6 (C-10), 29.7 (C-8), 29.7 
(C-9), 30.2 (C-6), 45.2 (C-3), 49.4 (C-5). 118.9 (C-1). 
 
2.4.22 Synthesis of N1,N1'-(heptane-1,7-diyl)bis(propane-1,3-diamine) (46). 
 
This compound was prepared by the same procedure as described for 34. The nitrile 
compound 42 (2.00 g, 8.02 mmol) was added to a solution of sodium hydroxide (0.74 
g, 18.50 mmol) in 95% ethanol (3 mL). Raney nickel (~ 0.3 g) was added to the mixture 
and introduced into a Parr hydrogenator. The Parr hydrogenator was purged twice with 
H2 and the reaction was carried out at 30 °C for 20 h at H2 pressure of 20 bar. After 20 
h the pressure fell down to lower than 5 bar suggesting that the hydrogen was 
consumed. The reaction mixture was filtered through Celite and the filtrate was 
evaporated under vacuum. The resulting mixture was then thoroughly extracted with a 
mixture of chloroform: methanol (85: 15 v/v, 8 x 10 mL). The combined organic 
fractions were dried (Na2SO4), filtered and the solvent was removed under reduced 
pressure to give a white solid (1.30 g, 63%). TLC analysis showed a major spot (Rf = 
0.1, ethanol: NH4OH, 2: 1 v/v). 
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IR: 3263 cm-1, (NH), 2922 cm-1, 2849 cm-1 (CH2); 
HRMS: Found 245.2750, C13H33N4 requires 245.2700 [M+H]
+; 
1H NMR (500 MHz; CDCl3): 0.91-1.22 (br, 6 H) (NH, NH2), 1.22-1.33 (m, 6 H, H-7, 
H-8), 1.39-1.48 (m, 4 H, H-6), 1.54-1.66 (m, 4 H, H-2), 2.51-2.59 (m, 4 H, H-5), 
2.59-2.68 (m, 4 H, H-3), 2.68-2.77 (m, 4 H, H-1); 
13C NMR (125 MHz; CDCl3): 27.5 (2 x C-7), 29.6 (C-8), 30.3 (2 x C-6), 34.2 (2 x C-
2), 40.7 (2 x C-1), 48.1 (2 x C-3). 50.3 (2 x C-5). 
The spectral data for this compound have been previously reported including mass and 
1H NMR data, but not 13C NMR data (Edwards et al., 1991). Our spectral data are in 
agreement with the reported data. 
 
2.4.23 Synthesis of N1,N1'-(octane-1,8-diyl)bis(propane-1,3-diamine) (47).  
 
This compound was prepared by the same procedure as described for 34. The nitrile 
compound 43 (2.00 g, 7.99 mmol) was added to a solution of sodium hydroxide (0.74 
g, 18.50 mmol) in 95% ethanol (3 mL). Raney nickel (~ 0.3 g) was added to the mixture 
and introduced into a Parr hydrogenator. The Parr hydrogenator was purged twice with 
H2 and the reaction was carried out at 30 °C for 20 h at H2 pressure of 20 bar. After 20 
h, the pressure fell down to lower than 5 bar suggesting that the hydrogen was 
consumed. The reaction mixture was filtered through Celite and the filtrate was 
evaporated under vacuum. The resulting mixture was then thoroughly extracted with a 
mixture of chloroform: methanol (85: 15 v/v, 8 x 10 mL). The combined organic 
fractions were dried (Na2SO4), filtered and the solvent was removed under reduced 
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pressure to give a white solid (1.28 g, 62%). TLC analysis showed a major spot (Rf = 
0.1, ethanol: NH4OH, 2: 1 v/v).  
IR: 3264 cm-1, (NH), 2924 cm-1, 2848 cm-1 (CH2); 
HRMS: Found 259.2919, C14H35N4 requires 259.2856 [M+H]
+; 
1H NMR (500 MHz; CDCl3): 0.93-1.24 (br, 6 H) (NH, NH2), 1.24-1.33 (m, 8 H, H-7, 
H-8), 1.40-1.51 (m, 4 H, H-6), 1.57-1.68 (m, 4 H, H-2), 2.51-2.61 (m, 4 H, H-5), 
2.61-2.69 (m, 4 H, H-3), 2.70-2.80 (m, 4 H, H-1); 
13C NMR (125 MHz; CDCl3): 27.5 (2 x C-7), 29.6 (C-8), 30.3 (2 x C-6), 34.2 (2 x C-
2), 40.7 (2 x C-1), 48.1 (2 x C-3). 50.4 (2 x C-5). 
This compound has been previously reported, but without spectral data (Edwards et 
al., 1991). 
 
2.4.24 Synthesis of N1,N1'-(decane-1,10-diyl)bis(propane-1,3-diamine) (48).  
 
This compound was prepared by the same procedure as described for 34. The nitrile 
compound 44 (2.00 g, 7.18 mmol) was added to a solution of sodium hydroxide (0.74 
g, 18.50 mmol) in 95% ethanol (3 mL). Raney nickel (~ 0.3 g) was added to the mixture 
and introduced into a Parr hydrogenator. The Parr hydrogenator was purged twice with 
H2 and the reaction was carried out at 30 °C for 20 h at H2 pressure of 20 bar. After 20 
h, the pressure fell down to lower than 5 bar suggesting that the hydrogen was 
consumed. The reaction mixture was filtered through Celite and the filtrate was 
evaporated under vacuum. The resulting mixture was then thoroughly extracted with a 
mixture of chloroform: methanol (85: 15 v/v, 8 x 10 mL). The combined organic 
fractions were dried (Na2SO4), filtered and the solvent was removed under reduced 
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pressure to give a white solid (1.58 g, 77%). TLC analysis showed a major spot (Rf = 
0.2, ethanol: NH4OH, 2: 1 v/v). 
IR: 3227 cm-1, (NH), 2893 cm-1, 2824 cm-1 (CH2); 
HRMS: Found 287.3252, C16H39N4 requires 287.3169 [M+H]
+; 
1H NMR (500 MHz; CDCl3): 0.94-1.17 (br, 6 H) (NH, NH2), 1.22-1.31 (m, 12 H, H-
7, H-8, H-9), 1.45 (q, J = 7.0 Hz, J = 7.0 Hz, 4 H, H-6), 1.62 (t, J = 7.0 Hz, 4 H, H-2), 
2.57 (t, J = 7.0 Hz, 4 H, H-5), 2.65 (t, J = 7.0 Hz, 4 H, H-3), 2.74 (t, J = 7.0 Hz, 4 H, 
H-1); 
13C NMR (125 MHz; CDCl3): 27.5 (2 x C-7), 29.7 (2 x C-8), 29.7 (2 x C-9) 30.3 (2 x 
C-6), 34.2 (2 x C-2), 40.7 (2 x C-1), 48.1 (2 x C-3). 50.4 (2 x C-5). 
The spectral data are in good agreement with those reported (Bradley et al., 1997). 
 
2.4.25 Synthesis of N1,N1'-(dodecane-1,12-diyl)bis(propane-1,3-diamine) (49). 
 
This compound was prepared by the same procedure as described for 34. The nitrile 
compound 45 (2.00 g, 6.52 mmol) was added to a solution of sodium hydroxide (0.74 
g, 18.50 mmol) in 95% ethanol (3 mL). Raney nickel (~ 0.3 g) was added to the mixture 
and introduced into a Parr hydrogenator. The Parr hydrogenator was purged twice with 
H2 and the reaction was carried out at 30 °C for 20 h at H2 pressure of 20 bar. After 20 
h, the pressure fell down to lower than 5 bar suggesting that the hydrogen was 
consumed. The reaction mixture was filtered through Celite and the filtrate was 
evaporated under vacuum. The resulting mixture was then thoroughly extracted with a 
mixture of chloroform: methanol (85: 15 v/v, 8 x 10 mL). The combined organic 
fractions were dried (Na2SO4), filtered and the solvent was removed under reduced 
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pressure to give a white solid (1.64 g, 80%). TLC analysis showed a major spot (Rf = 
0.2, ethanol: NH4OH, 2: 1 v/v). 
IR: 3263 cm-1, (NH), 2922 cm-1, 2849 cm-1 (CH2); 
HRMS: Found 315.3581, C18H43N4 requires 315.3482 [M+H]
+; 
1H NMR (500 MHz; CDCl3): 0.94-1.17 (br, 22 H, H-7, H-8, H-9, H-10) (NH, NH2), 
1.46 (q, J = 7.0 Hz, J = 7.0 Hz, 4 H, H-6), 1.62 (t, J = 7.0 Hz, 4 H, H-2), 2.57 (t, J = 
7.0 Hz, 4 H, H-5), 2.65 (t, J = 7.0 Hz, 4 H, H-3), 2.75 (t, J = 7.0 Hz, 4 H, H-1); 
13C NMR (125 MHz; CDCl3): 27.6 (2 x C-7), 29.7 (2 x C-8), 29.7 (4 x C-9, C-10), 30.3 
(2 x C-6), 34.2 (2 x C-2), 40.7 (2 x C-1), 48.1 (2 x C-3). 50.4 (2 x C-5). 
The spectral data previously reported for this compound are 1H NMR data only 
(Bradley et al., 1997). Our 1H NMR spectral data are in agreement with those data. 
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Increasing bacterial resistance is a great challenge to global health. Anti-microbial 
resistance (AMR) is spreading globally, decreasing the ability to fight epidemic 
infections and creating an ever more significant challenge to global health. Biofilms 
are a major source of the problem of AMR. About 80% of human bacterial infections 
are biofilm-related (Worthington et al., 2012, Barsoumian et al., 2015). It is much 
worse where the bacteria form biofilms because such biofilms are very tolerant to the 
body’s defence system and resist antibodies, phagocytosis, and antibiotics as biofilms 
represent a physical and diffusional barrier restricting their access to the bacteria in the 
biofilm. Bacterial cells within the biofilms are up to 1000-times more resistant to 
antibiotics than free floating planktonic cells (Hoiby et al., 2010). These biofilms are 
formed in clinical isolates and therefore the future of operations in hospitals (which 
typically all require antibiotic treatments) requires a solution to this AMR problem.  
 
Having synthesized designed polyamines as described in chapter 2, their biological 
activities against biofilms were evaluated. Polyamine starting materials and 
synthesized analogues were initially tested for their activity to prevent biofilm 
formation in 96-well plate assays using crystal violet staining method on three chosen 
S. aureus strains (Alhusein et al., 2015; Phuong et al., 2017). The first, MRSA 252, is 
a clinical isolate that was isolated in 1997 (Holden et al., 2004). This strain is resistant 
to several antibiotics including erythromycin, meticillin, and ciprofloxacin, and it was 
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responsible for the death of three patients due to septicaemia from this strain after a 
miniature outbreak (Holden et al., 2004). The second strain, S. aureus MSSA 15981, 
was isolated in the University Clinics of Navarra, Spain (Valle et al., 2003). It is able 
to produce strong, thick biofilms. The third strain, S. aureus NCTC6571 is a commonly 
used reference strain that was first described by Heatley (1944). For biofilms of MSSA 
15981 the EPS has been analysed and was shown to contain the extracellular 
polysaccharide N-acetylglucoseamine, decreasing the production N-
acetylglucoseamine completely prevented biofilm formation (Valle et al., 2003). The 
biofilm composition of these three strains were examined to see if there is a 
relationship between the activity of the polyamines and the biofilm composition. 
 
Compounds showing activity in preventing biofilm formation were then tested for their 
activity to disperse existing biofilm in 96-well plates by quantifying the amount of 
biofilm formed using crystal violet. In this, biomass (cells and EPS) are stained with 
an 0.1% crystal violet solution, after which the crystal violet is dissolved in 30% acetic 
acid and the visible absorbance measured using a UV-visible plate reader at λ = 595 
nm. Crystal violet stains live and dead cells and some components of the extracellular 
matrix of the biofilm, which gives information about the whole biofilm mass, but not 
viable counts within the biofilm. So, the active compounds were tested for their 
activity to prevent biofilm formation using the Miles-Misra method (Alhusein et al., 
2015), which gives clear information about the viable counts within the biofilm. 
Moreover, these active compounds were also tested for their activity to prevent biofilm 
formation and disperse preformed biofilms using Live/Dead stains by a confocal 
microscopy technique, which provides more information about the thickness of the 
biofilm and the spread of live and dead cells through each biofilm. Commonly used 
methods to quantify biofilms have been evaluated (Doll et al., 2016). The authors 
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concluded that LIVE/DEAD staining combined with the confocal laser-scanning 
microscopy (CSLM) method is favoured for detailed analysis of mature biofilms and 
initial adhesion, but its demanding time and cost make it unsuitable for rapid high-
throughput screening. sSimpler methods such as resazurin and crystal violet are time 
and cost effective and therefore preferred for rapid high-throughput screening. Crystal 
violet is not applicable for experiments detecting the antimicrobial activity, as dead 
bacterial cells are embedded within non-degraded biofilms (Doll et al., 2016). 
 
As previously discussed in chapter 1, the mechanism of action of polyamines is not 
yet well-established. In this thesis, the most active compounds were tested for their 
activity to prevent bacterial attachment to a surface, the very first step of biofilm 
formation. This test shows if the activity of polyamines is affecting the EPS component 
of the biofilm after the maturation of the biofilm or an earlier step. Active compounds 
were also tested for their effect on bacterial growth curve compared to control bacteria. 
This test will show if the biofilm inhibition refers to polyamine toxicity by inhibiting 
bacterial growth or to the inhibition of biofilm formation. In order to test the ability of 
polyamines to prevent biofilm formation, four naturally occurring polyamines, 
spermidine, spermine, norspermidine, and norspermine, known to be biologically 
active molecules (Cohen, 1998) were therefore selected as potentially 
microbiologically active natural products as the starting point in these studies. 
 
Norspermine (NS, 3.3.3) and norspermidine (NSD, 3.3) have 3-carbon atoms distance 
between each pair of amino-groups, while spermine and spermidine have an extra 
carbon atom as a methylene group. Spermine (S, 3.4.3) and norspermine (NS, 3.3.3) 
have four amino groups (two primary and two secondary amines) and are symmetrical 
molecules. They carry four positive charges at mammalian physiological pH. 
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Norspermidine (3.3) and spermidine (3.4) each have three amino groups (two primary 
amines and one secondary) and they each carry three positive charges at pH = 7.4. At 
such a pH, these linear polyamines are essentially fully charged. This follows from the 
Henderson-Hasselbalch equation which describes the relationship between pKa, pH, 
and the ratio of ionized to unionized species. Spermine for example carries 3.8 net 
positive charges at physiological pH on its four amino groups, following from its pKa 
values of 10.9, 10.1, 8.9, and 8.1 (potentiometry). Similarly, spermidine carries 2.9 net 
positive charges at pH = 7.4 on its three amino groups following from its pKa values 
of 10.8, 9.9, and 8.4 (potentiometry) (Blagbrough et al., 2011). 
 
The microbiological infections which are the targets of this research are growing on or 
in the host at the typical mammalian blood physiological pH = 7.4. S. aureus bacteria 
have cytoplasmic pH values in the range of 7.5 to 8.0 (Booth, 1985). Clearly, if the net 
charge is calculated at pH = 7.4, this will be comparable with the charge at pH = 7.5. 
Therefore, if polyamines enter microbiological cells, they will display a similar net 
positive charge and fold to adopt similar structures. Even in the slightly more basic 
bacterial milieu of pH = 8.0, they will be similarly charged. The distribution of positive 
charges on such poly-cationic molecules is important for their biological activity by 
affecting their interactions with macromolecular components of the cell surface or 









3.2 Results and discussion 
 
3.2.1 Effect of polyamines on biofilm formation 
 
The microbiological activities of these four selected naturally occurring polyamines to 
prevent biofilm formation were measured on the three S. aureus strains:  one MRSA 
(MRSA 252) and two MSSA strains (NCTC 6571 and MSSA 15981). 
 
In Figure 1 and in many subsequent figures, the control data are from untreated 
bacteria, normalised as a negative control. Figure 1a shows the activity of these selected 
polyamines in preventing biofilm formation in MRSA 252. All tested polyamines show 
low activity in MRSA 252 biofilms, the most active one was spermine at concentration 
= 0.3 mM with activity of only around 20% in preventing biofilm formation. Figure 1b 
shows their activity to prevent biofilm formation in S. aureus NCTC 6571, an MSSA 
strain. Spermine and spermidine were inactive against NCTC 6571 biofilm, but 
norspermidine and norspermine were active and prevented biofilm formation. The most 
active was norspermine at concentration = 0.5 mM which reduced biofilm by 85%. 
These results are in agreement with results previously reported (Kolodkin-Gal et al., 
2012). It should be noted that this Cell paper has been retracted. However, the reason 
for the retraction was not related to the activity of polyamines on biofilms. The active 
polyamines (norspermidine and norspermine) have 3-methylene groups distance 
between all amino groups while the inactive polyamines (spermidine and spermine) 
have an extra methylene group in their chemical structure. From this SAR, it may be 
concluded that repeating the 3-carbon atoms distance between the amino groups in 







Figure 1: The effects of norspermidine 3, spermidine 4, norspermine 6, and spermine 7 on 
biofilm formation in a) MRSA 252, b) NCTC 6571, c) MSSA 15981. The results are the 
average of three independent experiments, with each one replicated in 8 wells and normalised 
against Control (untreated bacteria). The error bars indicate the standard deviation. * p < 


















































































Figure 1c shows spermidine, spermine, norspermidine, and norspermine activity in 
preventing biofilm formation in MSSA 15981 strain. All tested polyamines show low 
activity in MSSA 15981 biofilms, the most active one was norspermine, which only 
resulted in 27% reduction of biofilm formation at concentration = 0.5 mM. 
Norspermidine and norspermine showed higher activity against NCTC 6571 strain 
comparing to this strain MSSA 15981. This variation in polyamine microbiological 
activities suggested the importance of an analysis of the composition of these bacterial 
strains biofilms, which could explain these laboratory observed variations. 
 
3.2.2 Biofilm composition studies 
 
The variance in polyamine activity between different bacterial strains may be due to 
the different biofilm compositions. The major components of biofilms can be identified 
by using a variety of substances. For example, in terms of the extracellular matrix, 
polysaccharide-based biofilms can be oxidised by sodium periodate, protein-based 
biofilms can be hydrolysed by enzymes such as proteinase K, and DNA-based biofilms 
can be hydrolysed by DNases such as DNase I. 
 
Sodium periodate (NaIO4, Figure 2) is an inorganic salt used to cleave the carbon-
carbon bond in certain sugars in which two the carbons constitute a vicinal diol (Xiu 
et al., 2010). This oxidation of the two secondary alcohol functional groups to two 
aldehydes occurs with carbohydrate ring cleavage. Sodium periodate salt can exist in 
two forms: sodium metaperiodate, which has the formula NaIO4, and sodium 
orthoperiodate, which has the formula Na2H3IO6. Both salts can be used as oxidising 






Figure 2: Cleavage of a polysaccharide 1,2 diol-by sodium metaperiodate. 
 
Proteinase K is a protease (Figure 3). It was isolated from an extract of the fungus 
Tritirachium album Limber and named after its ability to digest keratin in hair 
(Morihara and Tsuzuki, 1975). Proteinase K is an extracellular serine endopeptidase 
that has a broad-spectrum of activity against proteins and can work catalytically at a 
wide range of pH and temperature (Yang et al., 2016). This broad-spectrum makes it 
suitable for digesting the wide range of amino acid sequences comprising  the proteins 
that might be found in different bacterial biofilms. 
 
Figure 3: Cleavage of protein peptide bonds by proteinase K. 
 
DNase I (Deoxyribonuclease I) is a nuclease that hydrolyses DNA by the cleavage of 
phosphodiester bonds in the polynucleotide as shown in Figure 4. DNase I is a calcium-
dependent enzyme (Moor, 1981), thus calcium chloride was added to DNase I solution 





Figure 4: Cleavage of DNA by DNase I. 
 
  
Figure 5: The effects of sodium metaperiodate (NaP), proteinase K (PrK), and DNase I on 
preformed biofilms in NCTC 6571, MSSA 15981, and MRSA 252 strains. The results are 
the average of three experiments, with each one replicated in 8 wells and normalised against 
Control (untreated bacteria). The error bars indicate the standard deviation. ** p < 0.01, *** 



















Figure 5 shows the ability of sodium periodate, proteinase K, and DNase I to 
disassemble preformed biofilms in the three chosen bacterial strains. This provides 
important molecular information about the composition of their biofilms. 
 
MSSA 15981 and NCTC 6571 biofilms were both disrupted by sodium periodate, but 
not by proteinase K or DNase, indicating that the main component of the EPS in these 
biofilms is polysaccharide. MRSA 252 biofilm was disrupted by proteinase K (44%) 
and to a lesser extent by DNase (7%), but not by sodium periodate, thus the main 
component of the EPS in MRSA 252 biofilm is protein. Although the reduction in 
hydrolysis by proteinase K of MRSA 252 was not significant compared to the control, 
this strain is reported to be a protein-based biofilm (Phuong et al., 2017). 
 
According to the polyamine SAR hypothesis in the retracted Cell paper (Kolodkin-Gal 
et al., 2012), introduced in chapter 1, the amino groups of norspermidine and 
norspermine will bind to the acidic groups of the extracellular polysaccharide 
component and break the hydrogen bonds that form bridges between polysaccharide 
chains. These hydrogen bonds give the biofilm its strength and three dimensional 
structure. By breaking these bonds, norspermidine and norspermine can disassemble 
polysaccharide-based biofilms. So, these polyamines are expected to be inactive 
against the protein-based strain MRSA 252 and active against the polysaccharide-based 
strains NCTC 6571 and MSSA 15981. However, they were only active against NCTC 
6571, but not against MSSA 15981. Therefore, these two strains either have a different 
polysaccharide composition in which any acidic groups of the extracellular 
polysaccharides are not well aligned with the amino groups of the two polyamines, or 




3.2.3 Effect of polyamines on dispersing existing biofilm 
 
The activity of the four chosen polyamines (spermidine, spermine, norspermidine, and 
norspermine) to disperse preformed biofilms was measured on the three S. aureus 
strains:  MRSA 252, NCTC 6571, and MSSA 15981. 
 
Figure 6a shows the ability of the four chosen polyamines to disperse existing biofilm 
in MRSA 252. With the exception of norspermidine at concentration = 0.3 mM, all 
tested polyamines show no activity in MRSA 252 biofilms. However, norspermidine 
at concentration = 0.3 mM slightly increased biofilm mass. Figure 6b shows that tested 
polyamines have no activity to disperse existing biofilms in NCTC 6571. Figure 6c 
shows their lack of activity to disperse existing biofilms in MSSA 15981. 
 
All four chosen polyamines show no ability to disperse preformed biofilms in the three 
strains regardless of their biofilm composition. Norspermidine and norspermine were 
able to prevent biofilm formation in NCTC 6571, but did not disperse existing biofilms 
of the same strain. This shows that these polyamines act on biofilm formation only and 












Figure 6: The effects of norspermidine 3, spermidine 4, norspermine 6, and spermine 7 on 
dispersing existing biofilm in a) MRSA 252, b) NCTC 6571, c) MSSA 15981. The results 
are the average of three independent experiments, with each one replicated in 8 wells and 
normalised against Control (untreated bacteria). The error bars indicate the standard 












































































Norspermidine has been recently reported both to prevent biofilm formation and to 
disperse mature biofilms in S. aureus strains (Cardile et al., 2017). They showed that 
norspermidine reduces biofilm formation by about 80% and could disperse existing 
biofilms by 30%. However, they achieved these effects by using a very high 
concentration of norspermidine equal to 20 mM, which is 67-fold higher than the 
concentration we used which is 0.3 mM. However, the authors noted that 
norspermidine was toxic to S.aureus at 5 and 20 mM. A very recent study showed that 
such high concentrations of norspermidine and other polyamines inhibit planktonic 
growth of S. aureus strains (Li et al., 2018) 
 
As set out in chapter 2, compounds 25-28 (Figure 7) were designed and synthesized 
from the four selected natural polyamines (spermidine, spermine, norspermidine, and 
norspermine) in order to test the biological effect of minimising or at least restricting 
conformational rotation, by means of selectively incorporating the two amines 
separated by three methylene chain in an easily formed and yet specifically stable 










Figure 8: The effects of 25-28 on biofilm formation in a) MRSA 252, b) NCTC 6571, c) 
MSSA 15981 at concentration = 0.3 mM. The results are the average of three independent 
experiments, with each one replicated in 8 wells and normalised against Control (untreated 
































































Figure 8a shows the activity of compounds 25-28 to prevent biofilm formation in 
MRSA 252. All tested polyamines showed low activity in MRSA 252 biofilms, the 
most active ones were 27 and 28 which only reduced biofilm by 15%. Figure 8b shows 
their activity to prevent biofilm formation in NCTC 6571. All tested polyamines show 
low activity in NCTC 6571 biofilms, the most active was 27 which reduced biofilm by 
15%, but this reduction was not significant. Figure 8c shows their activity to prevent 
biofilm formation in MSSA 15981. All tested polyamines show low activity in MSSA 
15981 biofilms, the most active was 28 which reduced biofilm by 12%, but this 
reduction was not significant. 
 
Norspermidine and norspermine lose their activity against NCTC 6571 after 
cyclization. This could be due to the change in the distance between the amine groups 
(Figure 9), indicating that the three methylene spacer between the amines should be 
linear in order to achieve this kind of biological activity. 
 
 
Figure 9: Norspermidine and norspermine lose the three-linear carbon atoms distance 
between amino groups after cyclization to 25 and 27, respectively. 
 
Compounds 33-36 (Figure 10) were designed and synthesised from compounds 25-28 
respectively by the addition of two methylenes and a functional nitrile group to both 
free amines (secondary and primary) of the starting materials followed by reduction of 
both nitrile groups to their corresponding primary amines. Compounds 33-36 have two 
130 
 
additional amino groups separated by three methylene groups. Norspermidine and 
norspermine, which both have amino groups separated by three methylene groups from 
each other, show preventing biofilm formation activity in NCTC 6571 (Figure 1b). If 
this 3-carbon spacer is required for such microbiological activity, the final products 
(compounds 33-36) are expected to prevent biofilm formation in this strain. Indeed, 
the addition of two more positive charges might increase the activity compared to 
compounds 25-28, however, in reinforcing the 3.3 linear methylene pattern, biological 
activity might be mainly found in compound 33. 
 
Figure 10: Extended polyamine analogues tested for their activity against biofilms. 
 
Figure 11a shows the activity of compounds 33-36 to prevent biofilm formation in 
MRSA 252. All tested polyamines show low activity in MRSA 252 biofilms, the most 
active was 35 at concentration = 0.3 mM which reduced biofilm by 23% (Table 1). 
Figure 11b shows the activity of compounds 33-36 to prevent biofilm formation in 
NCTC 6571. All tested polyamines show activity to prevent biofilm formation in this 
strain. However, the activity of all compounds was less than norspermidine. The most 
active was 33 which reduced biofilm by 60% at concentration = 0.3 mM, and 46% at 
concentration = 0.5 mM, while norspermidine reduced biofilm by 85% at 
concentration = 0.5 mM (Tables 1, 2). The amine pattern of norspermidine is found 
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within 33. However, 33 is still less active than norspermidine at concentration = 0.5 
mM. Figure 11c shows the activity of compounds 33-36 to prevent biofilm formation 
in MSSA 15981 where all the tested polyamines showed low activity. The most active 
was 33 at concentration = 0.5 mM which reduced biofilm by 33% (Table 2). When 
compared with the previously discussed activity of compounds 25-28 in preventing 
biofilm formation in MSSA 15981 (Figure 8c), the addition of more amino groups 
separated by a three methylene spacer to compounds 25-28, to make compounds 33-
36, respectively increased their activity to prevent biofilm formation in MSSA 15981. 
 
Table 1: Percentage of biofilm reduction by polyamines (3-7, 25-28 and 33-36) at 
concentration = 0.3 mM compared to negative bacteria control in MRSA 252, NCTC 6571 
and MSSA 15981. 
 3 4 6 7 25 26 27 28 33 34 35 36 
MRSA 
252 
11 1 18 20 0 2 13 13 23 18 0 0 
NCTC 
6571 
48 5 61 7 3 7 16 12 60 57 56 56 
MSSA 
15981 
4 7 24 19 0 9 9 12 31 12 28 17 
 
Table 2: Percentage of biofilm reduction by polyamines (3-7 and 33-36) at concentration = 0.5 
mM compared to negative bacteria control in MRSA 252, NCTC 6571 and MSSA 15981. 
 3 4 6 7     33 34 35 36 
MRSA 
252 
15 15 17 17     2 7 0 6 
NCTC 
6571 
85 8 61 9     46 49 52 56 
MSSA 
15981 








Figure 11: The effects of 33-36 on biofilm formation in a) MRSA 252, b) NCTC 6571, c) 
MSSA 15981. The results are the average of three independent experiments, with each one 
replicated in 8 wells and normalised against Control (untreated bacteria). The error bars 




















































































The activity of 33-36 to prevent biofilm formation in the polysaccharide-based biofilm 
NCTC 6571 and MSSA 15981 strains (Figure 11b and c) was higher than the activity 
of their starting materials compounds 25-28, respectively (Figure 8b and c). However, 
in the case of the protein-based biofilm MRSA 252 strain there was no general trend. 
Figure 8a shows low activity of 27 and 28 to prevent biofilm formation in MRSA 252 
at concentration = 0.3 mM, but they lost their activity when converted into their 
analogues 35 and 36 (Figure 11a). In contrast, 25 showed no activity to prevent biofilm 
formation in MRSA 252 (Figure 8a), while its analogue 33 showed activity to prevent 
biofilm formation at concentration = 0.3 mM (Figure 11a). It could be that polyamines 
play some role in the production process of extracellular polysaccharides in NCTC 
6571 and MSSA 15981. However, the activity of polyamines appears to be strain 
dependent. 
 
Compounds 33-36 showed different activity to prevent biofilm formation in all three 
chosen strains, thus they were tested for their activity to disperse preformed biofilm in 
the same three bacterial strains (Figure 12). Figure 12a shows the activity of 33-36 to 
disperse existing biofilm in MRSA 252. All polyamines showed no significant 
reduction on biofilm mass. Figure 12b shows their total lack of activity to disperse 













Figure 12: The effects 33-36 on dispersing existing biofilm in a) MRSA 252, b) NCTC 
6571, c) MSSA 15981. The results are the average of three independent experiments, with 
each one replicated in 8 wells and normalised against Control (untreated bacteria). The error 
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Compounds 46-49 (Figure 13) were designed and synthesised, in part, inspired by the 
recently published lipidic molecules showing activity against biofilms (Hoque et al., 
2016; Wang et al., 2016). Compounds 46-49 were synthesised by the addition of two 
methylenes and a nitrile group to both ends of the starting diamine compounds to form 
42-45 followed by reduction of nitrile groups to their corresponding primary amines. 
Lipidic compound 49 was insoluble in water unless it contained a small amount of 
ethanol as a co-solvent (0.85% ethanol in water v/v). 
 
 
Figure 13: More lipidic polyamine analogues tested for their activity against biofilms. 
 
Recently, quaternised cationic small molecules were reported to have antibacterial and 
anti-biofilm activity by targeting the bacterial cell membrane (Hoque et al., 2016). The 
chemical structures of these compounds contain long hydrophobic chains flanked by 
permanent positive charges (Figure 14). However, the disadvantage of these 
compounds is their cytotoxicity. By changing the length of the hydrophobic chain, the 
authors minimised the toxicity against mammalian cells without losing antibacterial 
and anti-biofilm activity. Compounds 50 and 51 have shorter carbon-chains with 6 and 
8 carbons, respectively. These compounds show antibacterial and anti-biofilm activity. 
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By increasing the chain length to 10 and 12 carbons in 52 and 53, respectively, the 
antibacterial and anti-biofilm activity increased and the toxicity decreased. The most 
active and least toxic compound was compound 53, which incorporate a 12-carbon 
chain.  
 
Figure 14: Polyamines analogues reported to have antibacterial and anti-biofilm activity. 
 
Figure 15a shows the activity of compounds 46-48 to prevent biofilm formation in 
MRSA 252. Surprisingly, all tested polyamines show activity to increase biofilm 
formation in MRSA 252 biofilms, with the most active one being compound 48 at 
concentration = 0.5 mM which increased biofilm by 40%. This activity could be due 
to stress from these compounds on bacteria, which made the bacteria increase biofilm 







Figure 15: The effects of compounds 46-48 on biofilm formation in a) MRSA 252, b) 
NCTC 6571, c) MSSA 15981. The results are the average of three independent experiments, 
with each one replicated in 8 wells and normalised against Control (untreated bacteria). The 



















































































Figure 15b shows the activity of compounds 46-48 to prevent biofilm formation in 
NCTC 6571. Compound 48 showed low activity to prevent biofilm formation, the 
reduction of biofilm was 15% and 36% for concentrations 0.5 and 0.3 mM, 
respectively. Compounds 47 showed 52% and 56% reduction in biofilm formation for 
concentrations 0.5 and 0.3 mM, respectively. Compounds 46 showed 53% and 50% 
reduction in biofilm formation for concentrations 0.5 and 0.3 mM, respectively. Figure 
15c shows the activity of compounds 46-48 to prevent biofilm formation in MSSA 
15981. Compounds 46-48 show low activity in MSSA 15981 biofilms, the most active 
one was 48 at concentration = 0.3 mM which reduced biofilm by 32%.  
 
As compound 49 is insoluble in water, it was dissolved in ethanolic aqueous solution 
(0.85% v/v). Figure 16a shows the activity of compound 49 to prevent biofilm 
formation in MRSA 252. Correspondingly, in each assay of this polyamine, a dilute 
aqueous solution of ethanol (0.85% v/v) was used as a positive control. Compound 49 
prevented biofilm formation in MRSA 252 and showed ~99% reduction in biofilm 
mass. The presence of ethanol showed only a non-significant reduction in biofilm mass 
by 15%, which clearly indicated that the prevention of biofilm formation was due to 
compound 49, not caused by ethanol at that low concentration 
 
Figure 16b shows the activity of compound 49 to prevent biofilm formation in NCTC 
6571 showing over 99% reduction in biofilm mass. The presence of ethanol showed a 
non-significant reduction in biofilm mass by 20%, which clearly indicated that the 







Figure 16: The effects of compound 49 on biofilm formation in a) MRSA 252, b) NCTC 
6571, c) MSSA 15981. The results are the average of three independent experiments, with 
each one replicated in 8 wells and normalised against Control (untreated bacteria). The error 
bars indicate the standard deviation. Significance tests compared to control ** p < 0.01, *** 






































































Figure 16c shows the activity of compound 49 to prevent biofilm formation in MSSA 
15981 showing over 99% reduction in biofilm mass. The presence of such a low 
concentration of ethanol has almost no effect on biofilm mass, which clearly indicated 
that the prevention of biofilm formation was solely caused by compound 49. Recalling 
certain published molecules (Figure 14), these molecules perform their activity by 
targeting bacterial cell membranes (Hoque et al., 2016), which explains their non-
selective activity against bacteria. The structural resemblance between compound 49 
and compound 53 and the non-selective activity against bacterial strains suggests that 
49 may act by targeting bacterial cell membrane. Whereas compounds 33-36 are strain 
dependent and probably work by affecting QS or other toxicity mechanisms. 
 
Compounds 46-48 were tested for their activity to disperse preformed biofilms in the 
three chosen bacterial strains. Figure 17a shows the activity of compounds 46-48 to 
disperse existing biofilm of MRSA 252. All tested polyamines show higher biofilm 
mass in MRSA 252 biofilms, the most active one was 48 at concentration = 0.5 mM 
which increased biofilm by 30%. The result of a higher biofilm mass was expected as 
these compounds showed activity to increase biofilm formation for this strain in the 
previous section (Figure 15a). Figure 17b shows the activity of compounds 46-48 to 
disperse existing biofilm in NCTC 6571. All three compounds tested showed no effect 
on preformed biofilms in NCTC 6571. Figure 17c shows the activity of compounds 
46-48 to disperse preformed biofilm in MSSA 15981. All the tested polyamines show 
low activity in MSSA 15981 biofilms, the most active was 47 at concentration = 0.5 







Figure 17: The effects of compounds 46-48 on dispersing existing biofilm in a) MRSA 252, 
b) NCTC 6571, c) MSSA 15981. The results are the average of three independent 
experiments, with each one replicated in 8 wells and normalised against Control (untreated 
bacteria). The error bars indicate the standard deviation. * p < 0.05, ** p < 0.01, *** p < 
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Figure 18: The effects of compound 49 on dispersing existing biofilm in a) MRSA 252, b) 
NCTC 6571, c) MSSA 15981. The results are the average of three independent experiments, 
with each one replicated in 8 wells and normalised against Control (untreated bacteria). The 
error bars indicate the standard deviation. Significance tests compared to control * p < 0.05, 




































































As compound 49 is insoluble in water as mentioned in the previous section, a solution 
of ethanol in water (0.85% v/v) was therefore used as a positive control in each 
experiment. Compound 49 was dissolved in water solution containing a small amount 
of ethanol (0.85% v/v). Figure 18a shows the activity of compound 49 to disperse 
existing biofilm in MRSA 252. Figure 18b shows the activity of compound 49 to 
disperse existing biofilm in NCTC 6571. Compound 49 shows no activity to disperse 
preformed biofilms in either MRSA 252 or NCTC 6571.  
 
Figure 18c shows the activity of compound 49 to disperse existing biofilm in MSSA 
15981 where compound 49 shows low activity to disperse preformed biofilm in MSSA 
15981, biofilm mass decreased by 15% at concentration = 0.5 mM. In this experiment, 
all biofilms were grown under the same conditions. After 24 h, polyamines were added 
for another 24 h, then biofilm mass was measured. The reduction in biofilm mass might 
be due to preventing full maturation of the biofilm on the second day. 
 
3.2.4 Effect of polyamines on cellular viability 
 
The crystal violet assay is a good technique to measure the biofilm mass. Crystal violet 
dyes can stain live and dead cells, and biofilm components as well. After dissolving 
this stain, the absorbance measured gives us an indication about the whole biofilm 
mass. However, lower biofilm mass does not necessarily mean lower viable count. 
Here we tested 33 and 35 for their ability to prevent biofilm formation using the Miles-
Misra method by suspending the biofilm in PBS which was serially diluted and spotted 
on agar plates, incubated for 24 h, then colonies were counted. Figure 19 shows the 
relative number of colonies in biofilms treated with 33 and 35 to NCTC 6571 control. 





Figure 19: The effects of 33 and 35 on the number of live bacterial cells during biofilm 
formation in NCTC 6571. The number of colonies is the average of three independent 
experiments normalised against untreated bacteria control (1.5 X 10*7 CFU / mL). The error 
bars indicate the standard deviation. ** p < 0.01. Miles-Misra assay. 
 
This result shows that the reduction in the number of colonies is not significantly 
different from the reduction of biofilm mass using the crystal violet assay previously 
discussed in this chapter (Figure 11b), where the reduction of biofilm mass were 
measured for the same compounds and the same concentration on NCTC 6571, and 33 
and 35 reduced biofilm mass by 46% and 52% respectively (Table 3). This small non-
significant variation in the reduction percentages may be indicative that some bacterial 
cells in polyamine treated biofilms either died and were trapped within the biofilm or 
were freed as cells with planktonic status and therefore potentially removed in the 
various washing steps. Under the conditions used, sonication to disperse cells in 




























Table 3: The percentage reduction in mass and number of colonies in NCTC 6571 biofilms 
treated with 33 and 35 at concentration = 0.5 mM relative to NCTC 6571 control using crystal 
violet assay and Miles-Misra viable count assay. 
 33 35 
Reduction of the biofilm 
mass using the crystal violet 
assay 
46 (±0.12) 52 (±0.07) 
Reduction in the viable count 
in the biofilm using Miles-
Misra assay 
70 (±0.11) 69 (±0.06) 
 
3.2.5 Preventing biofilm formation analysed using confocal microscopy 
 
To investigate the ability of polyamines to prevent biofilm formation and disperse 
existing biofilms in a more qualitative technique, Live/Dead BacLight stains and 
confocal microscopy were used. Live/Dead BacLight stain contains two components: 
SYTO 9 that fluoresces green and propidium iodide that fluoresces red (Figure 20). 
These two dyes stain nucleic acids, however, SYTO 9 is able to penetrate both live and 
dead cells, but propidium iodide only penetrates dead cells (cells with a damaged 
membrane). When both dyes are added together, live cells appear green in colour, while 
dead cells, which contain both dyes, appear red in colour as propidium iodide is both a 





Figure 20: The chemical structure of SYTO 9 and propidium iodide dyes which present in 
BacLight stain. 
 
Figure 21 shows confocal laser scanning microscopy (CLSM) images from which to 
analyse the activity of 33 or 35 to prevent biofilm formation in the NCTC 6571 strain. 
Biofilms were grown on plastic coverslips. Applying 33 and 35 at concentration = 0.5 




       Control     Thickness = 19.7 µm  
        33      Thickness = 10.3 µm 
     35   Thickness = 10.7 µm 
 
Figure 21: Representative CLSM images showing the effects of 33 and 35 at concentration = 
0.5 mM on the thickness of NCTC 6571 biofilms grown on plastic coverslips. 
Side views, XZ (top) and YZ (right) are sagittal sections of the biofilm. 






Figure 22: Representative CLSM 3D images showing the 3D distribution of 24-h control 
NCTC 6571 biofilm (lower) and 33 (concentration = 0.5 mM) treated biofilm (upper) grown 
on plastic coverslips. Images analysed using ZEN lite program.  
 
The 3D structure of biofilms is not uniform, especially when polyamines are added. 
Figure 22 shows the 3D structure of control NCTC 6571 biofilm and 33 treated sample 
grown on plastic coverslips. The coverslips dimensions are 22 x 22 mm, image shown 
represents a 80 x 80 µm section of a random spot on the coverslip. Images show 
irregular shape of biofilm thickness in the 33 treated sample. This uneven distribution 
of biofilms resulted in unreliable measurements of biofilm thickness. 
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To quantify the ability of 33 and 35 to prevent biofilm formation statistically, biofilm 
thickness was measured in 5 previously determined random spots on coverslips. Figure 
23 shows the average thickness of NCTC 6571 biofilm formed in the presence of 33 or 
35 relative to NCTC 6571 control. 33 and 35 show lower biofilm thickness and reduce 
biofilm thickness by 46% and 48%, respectively. 
 
Figure 23: The effects of 33 and 35 on biofilm formation in NCTC 6571. The thickness is the 
average of three independent experiments, with each one measured in 5 random spots on each 
coverslip. The error bars indicate the standard deviation. * p < 0.05. Thickness was measured 
using confocal microscopy. 
 
This result is close to the previously discussed result in this chapter (Figure 11b), where 
the reductions in biofilm mass was measured for the same compounds and at the same 
concentration on NCTC 6571 using the crystal violet assay. Compounds 33 and 35 
reduced biofilm mass by 46% and 52% respectively (Table 4). However, the 
confidence in measuring biofilm mass by measuring thickness is limited by the 
variation of thickness from place to place on the coverslip, especially when treated with 
polyamines which makes the biofilm fragile with uneven distribution and irregular 
fragmentation after several washing steps. The modification of the surface on applying 























Table 4: The reduction percentage of mass and thickness of NCTC 6571 biofilms treated with 
33 and 35 at concentration = 0.5 mM relative to NCTC 6571 control using crystal violet 
assay and confocal microscopy assay. 
 33 35 
Reduction of the biofilm mass 
using the crystal violet assay 
46 (±0.12) 52 (±0.07) 
Reduction in the biofilm thickness 
using confocal microscopy 
48 (±0.13) 46 (±0.13) 
 
In order to determine the effects of two chosen antibiotics, vancomycin and 
tetracycline, on the three bacterial strains, they were assayed using crystal violet which 
reports on the total mass of the biofilm not specifically on live or dead cells. The 
minimum inhibitory concentration (MIC) of vancomycin against MRSA 252 is 2 
µg/mL. For both NCTC 6571 and MSSA 15981, the MIC is 4 µg/mL. For tetracycline, 
the MIC for MRSA 252 is 0.25 µg/mL, for NCTC 6571 the MIC is 0.5 µg/mL, and for 
MSSA 15981 the MIC is 4.0 µg/mL (Bolhuis, A., Personal communication, 04/06/18). 
Figure 24 shows the use of 10 X and 100 X MIC, but the results are all similar to 






Figure 24: The effects of antibiotics vancomycin and tetracycline on dispersing existing 
biofilms in a) MRSA 252, b) NCTC 6571, c) MSSA 15981 strains, assayed using the crystal 
violet stain. The results are the average of three independent experiments, with each one 










































































3.2.6 Dispersing existing biofilms analysed using confocal microscopy 
 
The most active compounds 33, 35, and 49 were measured for their ability to disperse 
preformed biofilms in combination with vancomycin. Vancomycin was used at 
concentration = 40 µg/mL, which is 10 X the MIC of NCTC 6571. Figure 25 shows 
confocal images for the effect of these compounds (with/without vancomycin) on 
NCTC 6571 preformed biofilms. No significant reduction was noticed on the thickness 
compared to the control. However, all polyamines showed more dead cells when 
combined with vancomycin compared to NCTC 6571 control or vancomycin alone. 
 
  














49      49 + V 
 
 
Figure 25: Representative CLSM images showing the effect of 33, 35, and 49 at concentration 
= 0.5 mM in combination with vancomycin (40 µg/mL) on preformed biofilms of NCTC 
6571 grown on plastic coverslips. Side views, XZ (top) and YZ (right) are sagittal sections of 
the biofilm. Scale Bar = 10 µm. Images analysed using ZEN lite program. 
 
Compound 49 was more active, which showed a higher intensity of red fluorescence 
compared to control and, significantly, to vancomycin alone. This demonstrates the 
higher ability of this combination of compound 49 and vancomycin to kill bacteria. 




3.2.7 Preventing attachment 
 
The mechanism of action of polyamines is not well-established yet. The previously 
discussed hypothesis in chapter 1 for the mechanism of action of polyamines 
(Kolodkin-Gal et al., 2012) suggested that norspermidine works by interaction with 
extracellular polysaccharides in the biofilm matrix. Recently, Ou and Ling suggested 
that norspermidine works by affecting QS (Cardile et al., 2017; Ou and Ling, 2017). 
We investigated whether polyamines prevent biofilm formation by affecting the EPS 
component of the biofilm after the maturation of the biofilm or if they act earlier in the 
initial adherence to surfaces. Figure 26 shows the effect of polyamines on the 
attachment of NCTC 6571 bacteria to the surface of 6-well plates. Tested polyamines 
were able to prevent adherence of cells in NCTC 6571, with compound 49 being the 
most active, and 48 the least active. With the exception of 48, all compounds show 
more than 69% lower cells attached to the plate surfaces. 48 shows 18% lower number 
of cells attached to the plate surfaces, 48 has also the lowest activity to prevent biofilm 
formation in NCTC 6571 and lowered biofilm mass by 18% (Figure 15b). These results 
show that the mechanism of action of polyamines on NCTC 6571 happens primarily 






Figure 26: The effect of polyamines (norspermidine 3, norspermine 6, 33-36, 46- 49, 
concentration = 0.5 mM) on the attachment of NCTC 6571 bacterial cells to 6-well plate 
polystyrene surface after 2 h of incubation. Attached bacterial cells were counted under 
microscope in 10 random spots on the plate surface (100 x, oil lens). The results are the 
average of 10 measurements in one experiment relative to control (40 attached cells). The 
error bars indicate the standard deviation. *** p < 0.001.  
 
This result supports the hypothesis that polyamines work by affecting the QS system. 
QS plays an important role all the way in biofilm formation steps from the attachment 
to the late maturation stage (Tomlin et al., 2005). Via QS, bacteria can regulate the 
expression of various genes that affect the bacterial attachment in S. aureus, e.g. 
affecting the expression of surface proteins or extracellular polysaccharides, the latter 
affects cell-to-cell adhesion (Deep et al., 2011; Kong et al., 2006). Polyamines could 






































3.2.8 Growth curves 
 
The activity of polyamines on biofilm mass could not be only due to their effect on the 
formation of biofilm, but they might also be toxic for bacterial cells, which will result 
in a lower number of bacterial cells, and a lower biofilm mass as a result. Active 
compounds were tested for their effect on NCTC 6571 growth by measuring the optical 
density (O.D.) of the medium containing NCTC 6571 bacteria as a control or NCTC 
6571 bacteria with one of the active polyamines every one hour for 13 hours. Figure 
27 shows the effect of the most active compounds (norspermidine, norspermine, 33-
36, 46-48, 49 (dissolved in 0.85% ethanol in water v/v), ethanol 0.85%)) on NCTC 
6571 growth. With the exception of compound 49, all compounds resulted in similar 
rate of growth for NCTC 6571, indicating that there is no toxic effect of these 
compounds on bacterial growth at the concentrations used and their activity is related 
to their effect on biofilms. However, compound 49 at concentration = 0.5 mM 
prevented bacterial growth. This reflects a toxic effect of this compound on NCTC 
6571 strain. 
 
This result, in addition to the previous results of the non-selective activity of 49 in 
preventing biofilm formation in all the three chosen strains, suggests that 49 which has 
a 12-methylene spacer kills bacteria, probably by targeting the cell wall in a similar 
way to the reported compound 53 discussed in Figure 14. Other polyamines with the 
shorter three-methylene spacers are strain selective and do not affect bacterial growth. 





Figure 27: The effect of polyamines (norspermidine 3, norspermine 6, 33-36, 44-48, 49 
dissolved in ethanol in water (0.85% v/v), and ethanol in water (0.85% v/v) as a solvent 
control for 49) on the growth of NCTC 6571 cells at concentration = 0.5 mM. 
O.D. was measured at 600 nm. The results are for one experiment. 
 
Following on from the interesting synergy result reported and discussed above (Figure 
25), obtained from CLSM images, experiments were designed and carried out to 
investigate if this synergistic activity between polyamines and antibiotics with respect 
to eradicating existing biofilms can be quantified, e.g. using the Miles-Misra method. 
Vancomycin (40 µg/mL, 10 x MIC) alone and in combination with polyamines (33, 35, 
or 49, 0.5 mM) was added to biofilms of NCTC 6571, grown for 24 h in a 96-well plate 
format. After another 24 h, live bacterial cells were counted using the Miles-Misra 
method. However, with the exception of the negative bacteria control, all the tested 
biofilms showed no viable cells, a surprising result at only 10 X MIC and a result not 
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In the Miles-Misra counting method, the biofilm was removed by scraping the biofilm 
out of the well thoroughly with a tip, transferring in to a 1 mL Eppendorf tube with 
PBS. Finally, the cells were sonicated for 5 min to disperse the cells from the biofilm, 
converting them to planktonic cells for the required serial dilution in the chosen 
counting method. Possibly, therefore, an amount of vancomycin adsorbed on the 
biofilm killed the bacterial cells during the time between the scraping out, the 
sonication, and the dilution steps. 
 
Figure 28: Polyamine analogues with antibacterial and anti-biofilm activity. 
 
Polyamine-based analogues 55 and 56 were recently reported (Wang et al., 2016), 
where amino groups are separated by methylene groups and flanked by thioamides and 
hydrophobic moieties (Figure 28). These molecules reduce biofilm formation and 
disperse existing biofilms in P. aeruginosa by targeting bacterial membranes. 
Compound 56 was able to inhibit biofilm formation in P. aeruginosa at concentration 
= 64 µg/mL. Whilst the biofilms of P. aeruginosa have not been investigated in this 
thesis, the synthetic polyamine analogue 33 showed inhibition of S. aureus NCTC 6571 






Figure 29: Lipidic polyamine analogues with antibacterial and anti-biofilm activity. 
 
Norspermidine-di-amino acid designed analogues conjugated to long lipophilic chains 
(compounds 57 and 58, Figure 29) have antibacterial activity (Konai et al., 2014; Konai 
and Haldar, 2015). Both compounds 57 and 58 were active against several Gram-
positive and Gram-negative bacteria species including S. aureus, E. faecium, E. coli, and 
K. pneumoniae. Moreover, compound 58 showed biofilm disrupting activity in S. aureus 
MTCC 737 at concentration = 60 µg/mL by targeting bacterial cell membranes. Whilst 
compound 33 was unable to disrupt preformed biofilms, it inhibited biofilm formation 
of S. aureus NCTC 6571 at concentration = 77 µg/mL (0.3 mM). 
 
These two analogues 57 and 58 are triamides with respect to the polyamine 
norspermidine moiety. Nevertheless, they each have four positive charges from the two 




In addition to the above polyamine conjugates 55 and 56 and the tetracationic 
polyamine derived triamides 57 and 58 being recently reported, whilst these studies 
were ongoing, several other research groups have reported on the inhibition of biofilm 
formation using either relatively simple natural products or on the dispersal of biofilms 
using an antimicrobial polypeptide analogue which is comparable with the more active 
molecules reported herein as it also carries three positive charges and is hydrophobic. 
Recently, anthranilamide-amine and guanidine conjugates which display antibacterial 
and anti-biofilm activity have also been reported (Kuppusamy et al., 2018). They are 
antimicrobial peptide mimicking compounds that act by disrupting cell membranes. 
Therefore, the presence of a positive charge and a hydrophobic moiety, in this case a 
naphthyl region, makes them comparable with the lipopolyamines designed and 
synthesized above. The biological activity arising from these phytochemical natural 
products and their analogues is briefly discussed in the context of such lipid-substituted 
positively charged molecules.  
 
The natural product ajoene 59, extracted from antibacterial garlic, Allium sativum, 
inhibits QS in P. aeruginosa (Figure 30). Fong et al. screened 480 compounds, and 
following quantitative SAR QS inhibition studies on 25 disulfides, they established that 
the allyl group could be replaced with other substituents, e.g. benzothiazole (Fong et 
al., 2017). Analogue 60 containing the disulfide bridge of ajoene was the most active, 





Figure 30: Disulfides with activity in preventing the formation of biofilms. 
 
A synthetic analogue 61 of the antimicrobial linear lipopeptide paenipeptin has recently 
been reported to disperse existing biofilm in S. aureus TTCC 29213 at concentration = 
40 µg/mL (Figure 31) (Moon et al., 2017). This compound carries three positive 
charges and hydrophobic residues; it acts by damaging cell membrane. 
 
Figure 31: Antimicrobial polypeptide analogue which disperses existing biofilms. 
 
In a very recent Nature Communication, iron oxide nanoparticles coated with 
carboxymethyl-dextran (Ferumoxytol), approved for the treatment of iron deficiency, 
have been reported to have biofilm disrupting activity by binding within the biofilm 
ultrastructure and generating free radicals from H2O2 that in situ kill bacteria by 




Biofilm disrupting activity for anthranilamides conjugated to a guanidine functional 
group, compounds 62 and 63 (Figure 32) has also recently been reported (Kuppusamy 
et al., 2018). They designed and prepared short peptidomimetics based on the 
anthranilic acid (2-aminobenzoic acid) moiety as their scaffold, terminating N-ethyl 
chains in primary amines, tertiary amines, N-trimethyl quaternised ammonium ions, 
and guanidines (Figure 32). The most active analogue fluoro-substituted 62 reduced 
preformed biofilms mass of S. aureus by 92% at concentration = 64 µM and bromo-
substituted 63 reduced preformed biofilms mass of S. aureus by 83% at concentration 
= 62.4 µM (Kuppusamy et al., 2018). These guanidines, like triamine 61, are 
antimicrobial peptide mimicking compounds that act by disrupting cell membranes. 
 





A paper from Hoque and co-workers (Hoque et al., 2016) reports how lipid amide, 
quaternised polyamines 64-67 can prevent biofilm formation and even eradicate 
established biofilms. Some of their molecules are bactericidal. The compounds share a 
common structural feature of having amino groups separated by a hydrocarbon chain 
and flanked by positively charged moieties. Their most active molecules contain a 
hydrocarbon chain of 6 to 12 methylene spacers between amine groups. 
 
  
Figure 33: Cationic molecules 64-67 reported to have activity to prevent biofilm formation 









The microbiological activity of polyamines with controlled different spatial distances 
between the amino groups to prevent biofilm formation and disperse existing biofilms 
has been investigated. The presence of more amino groups separated by three 
methylene spacers in the chemical structure of the polyamines increased their activity 
in preventing biofilm formation in S. aureus NCTC 6571. However, this activity is 
strain dependent as these polyamines show low activity against MRSA 252 and MSSA 
15981.  
 
Most tested polyamines showed no activity to disperse preformed biofilms. The low 
activity of the polyamines that was observed may be due to the prevention of further 
biofilm formation in the second day of the preformed biofilm dispersion experiment. 
So, it can be realistically concluded that all tested polyamines are inactive in dispersing 
existing biofilms. 
 
Vancomycin and tetracycline antibiotics showed no significant activity to disperse 
existing biofilms in the three chosen bacterial strains at concentrations up to the 100 
X their MIC values against planktonic cells. 
 
One polyamine, 49 did show high potency to prevent biofilm formation in all three S. 
aureus strains investigated in this thesis at concentration = 0.3 mM (94 µg/mL). 
Despite its low activity in dispersing existing biofilms, 49 (0.5 mM) showed activity 
to kill NCTC 6571 bacterial cells within preformed biofilms in combination with the 





Figure 33: The most active polyamines discovered in this thesis. 
 
In this thesis, the polyamine analogue 33 (Figure 33) showed inhibition of S. aureus 
NCTC 6571 biofilm formation at concentration = 77.2 µg/mL (0.3 mM) and reduced 
biofilm mass by 60%. Compound 35 also showed inhibition of S. aureus NCTC 6571 
biofilm formation at concentration = 98.0 µg/mL (0.3 mM) and reduced biofilm mass 
by 56%. The analogue 49 showed inhibition of all three S. aureus strains biofilm 
formation at concentration = 94.4 µg/mL (0.3 mM) and reduced biofilm mass by 99%. 
Compound 49 did not show significant reduction in preformed biofilm, but showed 




Materials and bacterial strains 
Norspermidine, norspermine, spermidine and spermine, were purchased from Sigma-
Aldrich. DNase I (bovine pancreas), proteinase K (Tritirachiam album), and sodium 
metaperiodate were purchased from Sigma-Aldrich. Ethanol and acetic acid were 
purchased from Fisher. Costar polystyrene 96-well plates (flat bottom, volume 0.36 
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mL, well diameter 7 mm) were purchased from Fisher. Tryptone Soya Broth (TSB) 
was purchased from Oxoid. Polyvinyl plastic coverslips (22 x 22 mm) were purchased 
from Electron Microscopy Science, Hatfield, UK. Crystal violet 1% was purchased 
from PRO-LAB Diagnostics. LIVE/DEAD BacLight was purchased from 
ThermoFisher. Ultraviolet-visible absorbance was measured at 595 nm using an 
FLUOstar Omega spectrophotometer (BMG Labtech, UK). Confocal images were 
obtained using a CLSM 880 (ZEISS, Germany). Bacterial strains Staphylococcus 
aureus MRSA 252 (Holden et al., 2004) MSSA 15981 (Pozzi et al., 2012), and NCTC 
6571 were kindly provided by Dr A. Bolhuis, Department of Pharmacy and 
Pharmacology, University of Bath, Bath BA2 7AY, UK. For overnight cultures, 
bacterial strains were cultured in TSB medium for 15-18 h. For biofilm tests, bacterial 
strains were cultured in TSB medium supplemented with 0.5% glucose. 
 
Effect of polyamines on biofilm formation 
All polyamines were tested in eight wells in three independent experiments. Biofilms 
were grown as described previously (Alhusein et al., 2015) with modifications. Briefly, 
bacteria (200 µL of 1/1000 dilution of an overnight culture) were grown in 96-well 
plates at 37 °C in TSB medium containing 0.5% glucose for negative control and TSB 
medium containing 0.5% glucose, different concentrations (0.3 and 0.5 mM) of 
polyamines on a three dimensional plate rotator (40 rpm). After 24 h growth, the plates 
were washed carefully (twice with 200 µL PBS) to remove planktonic bacteria and then 
dried at 60 °C for 1 h. Wells were then stained with 0.1% crystal violet solution and 
after 15 min the plates were washed with lukewarm tap water. Acetic acid (30%, 200 
µL) was added to dissolve the crystal violet and the visible absorbance was measured 




Biofilm composition studies 
All strains were tested in eight wells in three independent experiments as described 
previously (Kogan et al., 2006; Wang et al., 2004) with modifications. Biofilms were 
grown as described above. After 24 h growth, the plates were washed carefully (twice 
with 200 µL PBS). After that, PBS (200 µL), sodium periodate (10 mM in PBS), 
proteinase K (0.1 mg/mL PBS), or DNase (0.1 mg/mL DNase solution containing 1 
mM CaCl2 and 150 mM NaCl in PBS) were added to the different wells. After 2 h, the 
plates were washed carefully (twice with 200 µL PBS) to remove planktonic bacteria 
and then dried at 60 °C for 1 h. Wells were then stained with crystal violet and the 
visible absorbance was measured as described above. 
 
Effect of polyamines on dispersing existing biofilm 
All polyamines were tested in eight wells in three independent experiments. Biofilms 
were grown as described above. After 24 h medium was replaced with TSB medium 
containing 0.5% glucose for control and TSB medium containing 0.5% glucose and 
different concentrations (0.3 and 0.5 mM) of polyamines  on a three dimensional plate 
rotator (40 rpm). After 24 h growth, the plates were washed carefully (2 x with PBS) 
to remove planktonic bacteria and then dried at 60 °C for 1 h. Wells were then stained 
with crystal violet and the visible absorbance was measured as described above. 
 
Effect of antibiotics on dispersing existing biofilm 
Antibiotics vancomycin and tetracycline were tested in four wells in three independent 
experiments on each of the three chosen strains. Biofilms were grown as described 
above. After 24 h medium was replaced with TSB medium containing 0.5% glucose 
for control and TSB medium containing 0.5% glucose and different concentrations 
(MIC, 10 x MIC, or 100 x MIC) of the two antibiotics on a three dimensional plate 
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rotator (40 rpm). The minimum inhibitory concentration (MIC) of vancomycin against 
MRSA 252 is 2 µg/mL. For both NCTC 6571 and MSSA 15981, the MIC is 4 µg/mL. 
For tetracycline, the MIC for MRSA 252 is 0.25 µg/mL, for NCTC 6571 the MIC is 
0.5 µg/mL, and for MSSA 15981 the MIC is 4.0 µg/mL. MIC values represent the 
minimum inhibitory concentration of these antibiotics against planktonic bacterial 
cells. After 24 h growth, the plates were washed carefully (2 x with PBS) to remove 
planktonic bacteria and then dried at 60 °C for 1 h. Wells were then stained with crystal 
violet and the visible absorbance was measured as described above. 
 
Effect of polyamines on cellular viability 
The experiment was carried out using the Miles-Misra (Miles et al., 1938) method as 
described previously (Alhusein et al., 2013) with modifications. Briefly, S. aureus 
NCTC 6571 biofims were grown as above with or without polyamines (33 and 35 at 
concentration = 0.5 mM). After 24 h growth, the plates were washed carefully (2 x 
with PBS) to remove planktonic bacteria. The biofilm was removed by scraping the 
wells thoroughly with a tip and then transferred to a 1 mL Eppendorf tube with PBS 
and sonicated (Nickel electro Ltd, MU 1.5, 50-60 Hz, 20 °C) for 5 min to disperse the 
cells in the biofilm. The resulting suspension was then serially diluted to 10-6 in PBS. 
Ten microliters of each of 10-3, 10-4, 10-5, and 10-6 dilutions were spotted on to TSB 
agar plates and grown at 37 °C. After 24 h, the numbers of CFU were counted using 
the following equation: 
CFU/well = CFU counted x dilution factor x 100 
 
Preventing biofilm formation analysed using confocal microscopy 
The experiment was carried out as described previously (Alhusein et al., 2013) with 
modifications. Briefly, S. aureus NCTC 6571 (5 mL of 1/1000 dilution of an overnight 
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culture in TSB medium containing 0.5% glucose for control or TSB medium containing 
0.5% glucose and 0.5 mM of polyamines 33 and 35) were added to a 6-well plates. 
Polyvinyl plastic coverslips (22 x 22 mm), previously sterilized with ethanol (70%) and 
dried, were added to the wells and the well plates were incubated at 37 °C in static 
conditions. After 24 h, coverslips were washed with PBS (6 x) and stained with 
LIVE/DEAD BacLight mixture (500 µL, 50:50 v/v of each dye solution). The 
coverslips were kept in the dark for 15 min then washed with PBS (6 x) and mounted 
on glass slides with nail varnish. The stain was prepared from the manufacturer’s kit 
by dissolving the powder of each stain (SYTO9 and propidium iodide) in filter-
sterilized distilled water according to the manufacturer’s instructions. The two 
solutions were mixed 1:1 and applied to the biofilm sample. The mixture was stored 
frozen at -20 ºC for future use. Images analysed using ZEN lite program supplied by 
the ZEISS Company. 
 
Dispersing existing biofilms analysed using confocal microscopy 
The experiment was carried out as described previously (Alhusein et al., 2013) with 
modifications. Briefly, S. aureus NCTC 6571 biofilms were grown on polyvinyl 
plastic coverslips as described above. After 24 h, medium was replaced with fresh TSB 
medium containing 0.5% glucose for control or TSB medium containing 0.5% glucose 
and 0.5 mM of polyamines (33, 35, and 49) with/without vancomycin (40 µg/mL, 10 
x MIC) and grown at 37 °C in static conditions. After 24 h, coverslips were washed 
and stained as described above. The MIC values represent the minimum inhibitory 
concentration of vancomycin against planktonic bacterial cells. Images analysed using 






S. aureus NCTC 6571 (200 µL of 1/1000 dilution of an overnight culture) cells were 
grown in 6-well plates at 37 °C in TSB medium containing 0.5% glucose for control 
and TSB medium containing 0.5% glucose with 0.5 mM of polyamines (norspermidine, 
norspermine, 33-36, and 46-49, concentration = 0.5 mM) on a three dimensional plate 
rotator (40 rpm). After 2 h growth, the plates were washed carefully (2 x with PBS) to 
remove planktonic bacteria and then dried at 60 °C for 1 h. Wells were then stained 
with 0.1% crystal violet solution and, after 15 min, the plates were washed with 
lukewarm water. The number of attached cells was counted under a light microscope 
in 10 random spots on the plate surface (100 x, oil lens). 
 
Growth curve 
S. aureus NCTC 6571 (15 mL of 1/100 dilution of an overnight culture in TSB medium 
for control or TSB medium containing 0.5 mM of polyamines (norspermidine (NSD), 
norspermine (NS), 33-36, 44-48, and 49 dissolved in aqueous ethanol (0.85% v/v), and 
ethanol in water (0.85% v/v) as a positive control for 49) were added to a 50 mL 
universal tube. The O.D. was measured at 600 nm every hour for 13 h. The O.D. was 
plotted versus time (h). 
 
Statistical analysis 
Statistical analysis was performed using one-way ANOVA with a Dunnett post hoc 
test, where all groups compared to the untreated control group. * p < 0.05, ** p < 








Alhusein, N., Blagbrough, I. S., Beeton, M. L., Bolhuis, A., De Bank, P. A., 2015. 
Electrospun zein/PCL fibrous matrices release tetracycline in a controlled manner, killing 
Staphylococcus aureus both in biofilms and ex vivo on pig skin, and are compatible with 
human skin cells. Pharm. Res. 33, 237-246. 
Alhusein, N., De Bank, P. A., Blagbrough, I. S., Bolhuis, A., 2013. Killing bacteria within 
biofilms by sustained release of tetracycline from triple-layered electrospun micro/nanofibre 
matrices of polycaprolactone and poly(ethylene-co-vinyl acetate). Drug Deliv. Transl. Res. 3, 
531-541. 
Blagbrough, I. S., Metwally, A. A., Geall, A. J., 2011. Measurement of polyamine pKa 
values. In: Pegg, A. E., Casero, R. A., Jr. (Eds.), Polyamines: Methods and Protocols. 
Humana Press, Totowa, NJ, pp. 493-503. 
Booth, I. R., 1985. Regulation of cytoplasmic pH in bacteria. Microbiol. Rev. 49, 359-378. 
Cardile, A. P., Woodbury, R. L., Sanchez, C. J., Jr., Becerra, S. C., Garcia, R. A., Mende, K., 
Wenke, J. C., Akers, K. S., 2017. Activity of norspermidine on bacterial biofilms of 
multidrug-resistant clinical isolates associated with persistent extremity wound infections. 
Adv. Exp. Med. Biol. 973, 53-70. 
Chantrapromma, K., Ganem, B., 1980. The chemistry of naturally-occurring polyamines .A. 
Total synthesis of thermospermine. Tetrahedron Lett. 21, 2475-2476. 
Cohen, S. S., 1998. A guide to the polyamines. Chapter 22, pp 481-511. Oxford University 
Press, New York. 
Deep, A., Chaudhary, U., Gupta, V., 2011. Quorum sensing and bacterial pathogenicity: 
From molecules to disease. J. Lab. Physicians 3, 4-11. 
Doll, K., Jongsthaphongpun K. L., Stumpp, N. S., Winkel, A., Stiesch, M., 2016. Quantifying 
implant-associated biofilms: Comparison of microscopic, microbiologic and biochemical 
methods. J. Microbiol. Methods.130, 61-68 
172 
 
Fong, J., Yuan, M., Jakobsen, T. H., Mortensen, K. T., Delos Santos, M. M., Chua, S. L., 
Yang, L., Tan, C. H., Nielsen, T. E., Givskov, M., 2017. Disulfide bond-containing ajoene 
analogues as novel quorum sensing inhibitors of Pseudomonas aeruginosa. J. Med. Chem. 
60, 215-227. 
Hoiby, N., Bjarnsholt, T., Givskov, M., Molin, S., Ciofu, O., 2010. Antibiotic resistance of 
bacterial biofilms. Int. J. Antimicrob. Agents 35, 322-332. 
Holden, M. T. G., Feil, E. J., Lindsay, J. A., Peacock, S. J., Day, N. P. J., Enright, M. C., 
Foster, T. J., Moore, C. E., Hurst, L., Atkin, R., Barron, A., Bason, N., Bentley, S. D., 
Chillingworth, C., Chillingworth, T., Churcher, C., Clark, L., Corton, C., Cronin, A., 
Doggett, J., Dowd, L., Feltwell, T., Hance, Z., Harris, B., Hauser, H., Holroyd, S., Jagels, K., 
James, K. D., Lennard, N., Line, A., Mayes, R., Moule, S., Mungall, K., Ormond, D., Quail, 
M. A., Rabbinowitsch, E., Rutherford, K., Sanders, M., Sharp, S., Simmonds, M., Stevens, 
K., Whitehead, S., Barrell, B. G., Spratt, B. G., Parkhill, J., 2004. Complete genomes of two 
clinical Staphylococcus aureus strains: Evidence for the rapid evolution of virulence and drug 
resistance. Proc. Natl. Acad. Sci. U. S. A. 101, 9786-9791.  
Heatley, N. G., 1944. A method for the assay of penicillin. Biochem. J. 38,  61–65. 
Hoque, J., Konai, M. M., Sequeira, S. S., Samaddar, S., Haldar, J., 2016. Antibacterial and 
antibiofilm activity of cationic small molecules with spatial positioning of hydrophobicity: 
An in vitro and in vivo evaluation. J. Med. Chem. 59, 10750-10762. 
Kogan, G., Sadovskaya, I., Chaignon, P., Chokr, A., Jabbouri, S., 2006. Biofilms of clinical 
strains of Staphylococcus that do not contain polysaccharide intercellular adhesin. FEMS 
Microbiol. Lett. 255, 11-16. 
Kolodkin-Gal, I., Cao, S., Chai, L., Bottcher, T., Kolter, R., Clardy, J., Losick, R., 2012. A 
self-produced trigger for biofilm disassembly that targets exopolysaccharide. Cell 149, 684-
692. 
Konai, M. M., Ghosh, C., Yarlagadda, V., Samaddar, S., Haldar, J., 2014. Membrane active 
phenylalanine conjugated lipophilic norspermidine derivatives with selective antibacterial 
activity. J. Med. Chem. 57, 9409-9423. 
173 
 
Konai, M. M., Haldar, J., 2015. Lysine-based small molecules that disrupt biofilms and kill 
both actively growing planktonic and nondividing stationary phase bacteria. ACS Infect. Dis. 
1, 469-478. 
Kong, K. F., Vuong, C., Otto, M., 2006. Staphylococcus quorum sensing in biofilm formation 
and infection. Int. J. Med. Microbiol. 296, 133-139. 
Kuppusamy, R., Yasir, M., Yee, E., Willcox, M., Black, D. S., Kumar, N., 2018. Guanidine 
functionalized anthranilamides as effective antibacterials with biofilm disruption activity. 
Org. Biomol. Chem. 16, 5871-5888. 
Li, B., Maezato, Y., Kim, S. H., Kurihara, S., Liang, J., Michael, A. J., 2018. Polyamine-
independent growth and biofilm formation, and functional spermidine/spermine N-
acetyltransferases in Staphylococcus aureus and Enterococcus faecalis. in press Mol. 
Microbiol. [preprint]. doi:10.1111/mmi.14145. 
Liu, Y., Naha, P. C., Hwang, G., Kim, D., Huang, Y., Simon-Soro, A., Jung, H.-I., Ren, Z., 
Li, Y., Gubara, S., Alawi, F., Zero, D., Hara, A. T., Cormode, D. P., Koo, H., 2018. Topical 
ferumoxytol nanoparticles disrupt biofilms and prevent tooth decay in vivo via intrinsic 
catalytic activity. Nat. Commun. 9, 2920. 
Miles, A. A., Misra, S. S., Irwin, J. O., 1938. The estimation of the bactericidal power of the 
blood. J. hyg. (Lond). 38, 732-749. 
Moon, S. H., Zhang, X., Zheng, G., Meeker, D. G., Smeltzer, M. S., Huang, E., 2017. Novel 
linear lipopeptide paenipeptins with potential for eradicating biofilms and sensitizing gram-
negative bacteria to rifampicin and clarithromycin. J. Med. Chem. 60, 9630-9640. 
Moore, S. 1981. Pancreatic DNase. In The Enzymes (eds. P.D. Boyer et al.), 3rd edn. 14, 
281-296. Academic Press, New York. 
Morihara, K., Tsuzuki, H., 1975. Specificity of proteinase K from Tritirachium album limber 
for synthetic peptides. Agric. Biol. Chem. 39, 1489-1492. 
Ou, M. Z., Ling, J. Q., 2017. Norspermidine changes the basic structure of S. mutans biofilm. 
Mol. Med. Rep. 15, 210-220. 
174 
 
Phuong, N. T. M., Van Quang, N., Mai, T. T., Anh, N. V., Kuhakarn, C., Reutrakul, V., 
Bolhuis, A., 2017. Antibiofilm activity of α-mangostin extracted from Garcinia mangostana 
L. against Staphylococcus aureus. Asian Pac. J. Trop. Med. 10, 1154-1160. 
Pöllänen, M. T., Paino, A., Ihalin, R., 2013. Environmental stimuli shape biofilm formation 
and the virulence of periodontal pathogens. Int. J. Mol. Sci. 14, 17221-17237. 
Pozzi, C., Waters, E. M., Rudkin, J. K., Schaeffer, C. R., Lohan, A. J., Tong, P., Loftus, B. J., 
Pier, G. B., Fey, P. D., Massey, R. C., O'Gara, J. P., 2012. Methicillin resistance alters the 
biofilm phenotype and attenuates virulence in Staphylococcus aureus device-associated 
infections. PLoS Pathog. 8, e1002626. 
Tomlin, K. L., Malott, R. J., Ramage, G., Storey, D. G., Sokol, P. A., Ceri, H., 2005. 
Quorum-sensing mutations affect attachment and stability of Burkholderia cenocepacia 
biofilms. Appl. Environ. Microbiol. 71, 5208-5218. 
Xiu, A. H., Kong, Y., Zhou, M. Y., Zhu, B., Wang, S. M., Zhang, J. F. 2010. The chemical 
and digestive properties of a soluble glucan from Agrobacterium sp ZX09. Carbohydr. 
Polym. 82, 623-628  
Wang, B., Pachaiyappan, B., Gruber, J. D., Schmidt, M. G., Zhang, Y. M., Woster, P. M., 
2016. Antibacterial diamines targeting bacterial membranes. J. Med. Chem. 59, 3140-3151. 
Wang, X., Preston, J. F., Romeo, T., 2004. The pgaabcd locus of Escherichia coli promotes 
the synthesis of a polysaccharide adhesin required for biofilm formation. J. Bacteriol. 186, 
2724-2734. 
Worthington, R. J., Richards, J. J., Melander, C., 2012. Small molecule control of bacterial 
biofilms. Org. Biomol. Chem. 10, 7457-7474. 
Yang, H., Zhai, C., Yu, X., Li, Z., Tang, W., Liu, Y., Ma, X., Zhong, X., Li, G., Wu, D., Ma, 
L., 2016. High-level expression of proteinase K from Tritirachium album limber in Pichia 








Biofilm formation represents a significant mechanism by which pathogens are able to 
evade the human body immune system and antimicrobial treatments. Here we 
demonstrate the synthesis of linear and novel cyclic polyamines containing different 
spatial distances between the amino groups and investigate their effects to prevent 
biofilm formation and to disperse existing biofilms. Different techniques have been 
used to evaluate the anti-biofilm activity of the synthesised compounds including:  
crystal violet assay, confocal microscopy with Live/Dead BacLight stains, and 
utilising the Miles-Misra method for viable cell counting. 
 
A variety of solution methods have been used to synthesise the designed final products. 
Analogues were designed on the basis of the chemical structures of norspermidine, 
norspermine, spermidine, and spermine polyamines, which have been reported to have 
preventing biofilm formation and dispersing preformed biofilm activities on different 
bacterial strains. 
 
The very high polarity of polyamines represents a defining feature in the synthesis, 
extraction, and purification of final products. However, large scale synthesis of 
polyamines facilitates the extraction of more pure final products. Different synthetic 
methods have been investigated in detail to reduce nitrile groups to primary amines, 
but they failed either due to incomplete reduction of the nitrile groups or it was hard 
to extract the final products from the reaction medium. It was determined 
experimentally that the complete reduction of aliphatic nitrile groups to primary 
amines can be performed via catalytic hydrogenation using Raney nickel catalyst 
under 1 atm pressure of hydrogen and in a basic medium, which resulted in a pure 
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product in high yield. However, the high polarity of polyamines still remains a 
challenge to extract the final product from the reaction mixture in an efficient manner. 
 
The spectral data of synthesised compounds that have not been fully assigned or have 
been mis-assigned in literature were unambiguously assigned. The assignments were 
performed using MS and 1D and 2D NMR spectroscopic data supported by the 
theoretically calculated values of the 13C chemical shifts of these compounds. 
 
The activity of polyamines tested in this thesis to prevent biofilm formation with the 
exception of compound 49 is strain dependent. Their activity to prevent biofilm 
formation is performed by preventing bacterial attachment to surfaces, the first step of 
biofilm formation. That polyamines interfere with bacterial attachment to surfaces 
supports the hypothesis that polyamines act by affecting QS system which is involved 
in the attachment process. 
 
All the tested polyamines have low activity to disperse preformed biofilms. This low 
activity occurred mostly because of the inhibition of further growth of biofilm more 
than dispersing existing biofilms. Two novel polyamines 33 and 35 show activity to 
prevent biofilm formation in NCTC 6571 and MSSA 15981 strains. The combination 
of these polyamines with vancomycin shows higher activity to kill bacteria inside 
preformed biofilms than vancomycin alone in the NCTC 6571 strain. Compound 49 
shows antibacterial activity and prevents biofilm formation in all three S. aureus 
strains used in this thesis and shows high activity to kill bacterial cells within 




In future chemical work, further modifications could be made to the two lead 
polyamines, the mono-hexahydropyrimidine 33 and the di-hexahydropyrimidine 35. 
These could be converted into open-chain (linear) polyamines which would still carry 
a similar positive charge at physiological pH. Their biological activity could be further 
investigated to go beyond MRSA252 , NCTC 6571, and MSSA 15981 strains in order 
to investigate bacterial strain dependence. Linear polyamine 49, which shows 
antibacterial activity and prevents biofilm formation in the above strains, could be 
converted to its di-guanidine adduct and extended on both termini with acrylonitrile 
(followed by reduction) to see if such modifications enhance its biological activity. 
 
Based on the results of this thesis, polyamines could be useful in preparing surface 
coatings of medical devices to prevent the formation of biofilms. This will be of great 
interest in reducing the spreading of bacterial infections for regularly used medical 
devices. In addition, polyamines could be useful in the topical treatment of bacterial 
skin infections which protect themselves by the formation of biofilms. This potential 
use is especially important when combined with the application of antibiotics. The 
presence of polyamines in combination with antibiotics may decrease the required 
dose of antibiotics and thus decrease the risk of resistance that follows from the usage 
of high antibiotic doses.  
 
A combination of polyamines with other antibacterial agents, e.g. silver ions, could 
potentially be used to prevent pipe blockage in water distribution system.  
 
The evaluation of the impact following these proposed applications of the novel 
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The growth in antibiotic resistance in bacteria creates an ever more significant challenge to global 
health. One important driver of resistance is the formation of biofilms, in which cells may be 100-1000-fold 
more resistant to antibiotics as compared to free floating planktonic bacteria.1 This research project is 
aimed at developing novel compounds that prevent or disrupt biofilm formation and thereby can restore 
or enhance the activity of co-administered antibiotics. 
 
 We are investigating the effects of natural polyamines and their analogues in preventing biofilm 
formation in Staphylococcus aureus strains which produce biofilms of significantly different composition. 
The designed polyamine analogues are based on the naturally occurring polyamines spermidine, spermine, 
norspermidine, and norspermine. Some of these and their synthetic analogues contain two three-carbon 
spacers between amino groups, e.g. norspermidine and norspermine. 
 
 Polyamines are thought to be active by targeting the exopolysaccharide component of the 
extracellular polymeric substance (EPS) in the biofilm matrix.2 However, the composition of the EPS 
varies greatly between S. aureus strains, and we therefore investigated the effects of polyamines on three 
different S. aureus strains. Of those three strains, two strains has a polysaccharide-based biofilm, whereas 
the third had a protein-based biofilm. Surprisingly, norspermidine and norspermine, each containing two 
3-carbon spacers, were active against only one strain of the two polysaccharide-based strains. This 
suggests that certain polyamines may disrupt biofilms by targeting specific polysaccharides of specific 
bacterial strains, or that polyamines have an entirely different target and their mechanism of action is not 
related to interaction with exopolysaccharides. Corroborating earlier reports, spermidine and spermine, 
which have asymmetrically spaced polyamines, were not active against any strain, indicating that the 
distance between the amine groups in polyamines is a key factor in the SAR of polyamines. As expected, 
no activity was of polyamines was found against a biofilm that contained mainly protein in the EPS. 
Further investigation is required to determine the true target of polyamines, and to investigate whether 
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Summary 
 
The growth in antibiotic resistance in bacteria creates an ever more significant challenge to global health. 
One important driver of resistance is the formation of biofilms, in which cells may be 100-1000-fold more 
resistant to antibiotics as compared to free floating planktonic bacteria.1 Polyamines are thought to be 
active by targeting the exopolysaccharide component of the extracellular polymeric substance (EPS) in the 
biofilm matrix.2 We are investigating the effects of polyamines and their analogues on three different S. 
aureus strains. Of those three strains, two strains have a polysaccharide-based biofilm, whereas the third 
has a protein-based biofilm. Surprisingly, norspermidine and norspermine, each containing two 3-carbon 
spacers, were active against only one strain of the two polysaccharide-based strains (Fig. 1). Norspermine 
cyclic analogue NS1 show high activity to prevent biofilm formation in NCTC 6571, while other cyclic and 
acrylonitrilic analogues show low activity in preventing biofilm formation (Fig. 1). The amine properties of 
nitrogen, the distance between the amine groups and the symmetry in polyamines is a key factor in the SAR 
of polyamines disrupting biofilms. However, the mechanism of action of polyamines is still unclear.  
 
Figure 1. The effects of four polyamines (left): spermine (S), Spermidine (SD), norspermine (NS), and norspermidine 
(NSD), and their cyclic analogues (right): spermine (S1), spermidine (SD1), norspermine (NS1) and norspermidine 
(NSD1) on biofilm formation in MRSA 252, NCTC 6571 and MSSA 15981. Concentration = 0.3 mM. 
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Novel polyamines prevent biofilm formation in Staphylococcus aureus NCTC 6571 strain 
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Aims:  We are investigating the effects of natural polyamines and their analogues in preventing biofilm formation in 
Staphylococcus aureus strains which produce biofilms of significantly different composition. 
 
Introduction:  The growth in antibiotic resistance in bacteria creates an ever more significant challenge to global 
health. One important driver of resistance is the formation of biofilms biological barriers, whereby cells may become 
100-1000-fold more resistant to antibiotics as compared to free-floating planktonic bacteria.  
 
Methods:  The polyamine analogues were designed by the addition of further amine functional groups, each with a 3-
carbon spacer attached, on to naturally occurring polyamines. They were synthesized, purified, characterized, and 
tested against biofilm formation and preformed biofilms using a crystal violet assay on three S. aureus strains, MRSA 
252, NCTC 6571, and MSSA 15981. Polyamines were also tested for activity in dispersing existing biofilms in 
combination with vancomycin using confocal microscopy and Live/Dead staining. 
 
Results:  The designed polyamine analogues are based on the naturally occurring polyamines spermidine, spermine, 
norspermidine, and norspermine. The latter two compounds, each containing two 3-carbon spacers, were active in 
preventing biofilm formation in the NCTC 6571 strain. These polyamines were not active against the other strains. 
Twenty polyamine analogues were synthesised of which four novel compounds showed activity in preventing biofilm 
formation in the NCTC 6571 strain. The most active compound reduced the biofilm mass by more than 65% at a 
concentration of 0.5 mM. In dispersing exicting biofilms, the most active compound reduced biofilm mass by more 
than 25 % at a concentration of 0.3 mM. However, there was no synergy with vancomycin (Figure 1). 
 
 
      
               Control          Vancomycin   NSD1  NSD1 + Vancomycin 
    Thickness = 36 µM       Thickness = 26 µM        Thickness = 25 µM   Thickness = 23 µM 
Fig. 1. Confocal microscopy images showing NSD1 disperses preformed biofilms in combination with vancomycin. 
 
 
Conclusions:  The distance between the amine groups and the symmetry in polyamines is a key factor in the 
structure-activity relationship (SAR) of polyamines disrupting biofilms. This activity against these clinically important 
biological barriers was also shown to be strain dependent. The mechanism of action of polyamines is still unclear but 
they act on carbohydrate-rich biofilms much more effeciently than on DNA- or proteine-rich biofilms . 
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The growth in antibiotic resistance in bacteria creates an ever more significant challenge to global 
health. One important driver of resistance is the formation of biofilms, in which cells may be 100-
1000-fold more resistant to antibiotics as compared to free floating planktonic bacteria.a  We are 
investigating the effects of natural polyamines and their analogues in preventing biofilm formation in 
Staphylococcus aureus strains which produce biofilms of significantly different composition. The 
designed polyamine analogues are based on the naturally occurring polyamines spermidine, 
spermine, norspermidine, and norspermine. Some of these and their synthetic analogues contain 
two three-methylene spacers between amino groups, e.g. norspermidine and norspermine. 
Polyamines are thought to be active by targeting the exopolysaccharide component of the 
extracellular polymeric substance (EPS) in the biofilm matrix.b However, the composition of the EPS 
varies greatly between S. aureus strains, and we therefore investigated the effects of polyamines on 
three different S. aureus strains. Of those three strains, two strains have a polysaccharide-based 
biofilm, whereas the third has a protein-based biofilm. Surprisingly, norspermidine and norspermine, 
each containing two 3-carbon spacers, were active against only one strain of the two polysaccharide-
based strains. This suggests that certain polyamines may disrupt biofilms by targeting specific 
polysaccharides of specific bacterial strains, or that polyamines have an entirely different target and 
their mechanism of action is not related to interaction with exopolysaccharides. Corroborating earlier 
reports, spermidine and spermine, which have asymmetrically spaced polyamines, were not active 
against any strain, indicating that the distance between the amine groups in polyamines is a key 
factor in the SAR of polyamines. As expected, no activity of polyamines was found against a biofilm 
that contained mainly protein in the EPS. Therefore, polyamines may interact with certain 
polysaccharides. 
Cyclic analogues of the four primary polyamines were tested and show almost no activity in 
preventing biofilm formation. Cyclization decreases the activity of the active polyamines in 
preventing biofilm formation. Further investigation is required to determine the true target of 
polyamines, and to investigate whether polyamines may have clinical use. 
We thank Al Isra University, Amman, Jordan, for the financial support of this research by a 
scholarship to RA.  
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The growth in antibiotic resistance in bacteria creates an ever more significant challenge to global health. 
One important driver of resistance is the formation of biofilms, in which cells may be 100-1000-fold more 
resistant to antibiotics as compared to free floating planktonic bacteria.1 Polyamines are thought to be 
active by targeting the exopolysaccharide component of the extracellular polymeric substance (EPS) in 
the biofilm matrix.2 We are investigating the effects of polyamines and their analogues on three different 
S. aureus strains. Of those three strains, two strains have a polysaccharide-based biofilm, whereas the 
third has a protein-based biofilm. Surprisingly, norspermidine and norspermine, each containing two 3-
carbon spacers, were active against only one strain of the two polysaccharide-based strains (Fig. 1). 
Norspermine cyclic analogue NS1 show high activity to prevent biofilm formation in NCTC 6571, while 
other cyclic and acrylonitrilic analogues show low activity in preventing biofilm formation (Fig. 1). The 
amine properties of nitrogen, the distance between the amine groups and the symmetry in polyamines is 
a key factor in the SAR of polyamines disrupting biofilms. However, the mechanism of action of 
polyamines is still unclear.  
 
Figure 1. The effects of four polyamines (left): spermine (S), Spermidine (SD), norspermine (NS), and 
norspermidine (NSD), and their cyclic analogues (right): spermine (S1), spermidine (SD1), norspermine (NS1) and 
norspermidine (NSD1) on biofilm formation in MRSA 252, NCTC 6571 and MSSA 15981. Concentration = 0.3 mM. 
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S U M M A R Y 
We are investigating the effects of natural polyamines and their analogues in 
preventing biofilm formation in three Staphylococcus aureus strains which express 
biofilms of significantly different composition. The designed polyamine analogues 
contain two three-carbon spacers between amino groups and this is apparently a 
requirement for biological activity. This activity differs depending upon the 




The growth in antibiotic resistance in bacteria creates 
an ever more significant challenge to global health. 
One important driver of resistance is the formation of 
biofilms (Fig. 1), in which cells may be 100-1000-fold 
more resistant to antibiotics as compared to free 
floating planktonic bacteria Hoiby (2010). 
 
Fig. 1. Biofilm formation stages:  1. Attachment of free 
planktonic cells to a surface. 2. Bacterial cells start to 
anchor to each other under the effect of quorum sensing, 
forming small colonies. These colonies start to secrete 
extracellular polymeric substances which form the biofilm. 
3. The biofilm matures by cell growth and division. 4. 
Triggered by e.g. nutrient depletion, cells in the biofilm 
disperse allowing the formation of new colonies elsewhere. 
We are investigating the effects of natural polyamines 
and their analogues in preventing biofilm formation 
in Staphylococcus aureus strains which produce 
biofilms of significantly different composition. The 
designed polyamine analogues are based on the 
naturally occurring polyamines spermidine, 
spermine, norspermidine, and norspermine. Some of 
these and their synthetic analogues contain two 
three-methylene spacers between amino groups, e.g. 
norspermidine and norspermine. 
MATERIALS AND METHODS 
 1) Analogue synthesis (Fig. 2):  Each 
polyamine (1 g each of spermidine, spermine, 
norspermidine, or norspermine) was dissolved in 
distilled water (30 mL). The aqueous solution was 
then cooled to 5 °C and paraformaldehyde (1 or 2 eq.) 
was added. The mixture was stirred for 1 h at 20 °C 
and then thoroughly extracted with chloroform.  
Fig. 2. Synthetic schemes based on the four primary 
polyamines. Reagents and conditions:  (a) (i) H2O, 5°C, 
(ii) paraformaldehyde, 1 h. 
 2) Biofilm assay:  Bacteria (200 µL) were 
grown in 96-well plates at 37 °C in TSB medium 
containing 0.5 % glucose and different concentrations 
of polyamines. After 24 h growth, the plates were 
washed (3 x with 200 µL 0.9 % aq. NaCl per well) to 
remove planktonic bacteria, and then dried at 60 °C 
(1 h). Wells were then stained with 0.1% aq. crystal 
violet solution (200 µL) and after 15 min the plates 
were washed by immersing in warm water (3 x). 
Acetic acid (30%, 200 µL) was then added to each 
well and the visible absorbance was measured using 
a UV-visible plate reader at λ = 595 nm. 
RESULTS AND DISCUSSION 
Polyamines are thought to be active by targeting the 
exopolysaccharide component of the extracellular 
polymeric substance (EPS) in the biofilm matrix 
Bottcher (2013). However, the composition of the EPS 
varies greatly between S. aureus strains, and we 
therefore investigated the effects of polyamines and 
their analogues (Fig. 2) on three different S. aureus 
strains. Of those three strains, two strains have a 
polysaccharide-based biofilm, whereas the third has a 
protein-based biofilm. Surprisingly, norspermidine 
(NSD) and norspermine (NS), each containing two 3-
carbon spacers, were active against only one strain of 
the two polysaccharide-based strains (Fig. 3). 
The, norspermine cyclic analogue NS1 (with two 
hexahydropyrimidine rings) shows potent activity to 
prevent biofilm formation in NCTC 6571 cells, while 
other analogues show only low activity in preventing 
biofilm formation (Fig. 4). 
 
 
Fig. 3. The effects of polyamines:  spermine (S), spermidine 
(SD), norspermine (NS), and norspermidine (NSD) on 
biofilm formation in MRSA 252, NCTC 6571 and MSSA 
15981 cells. Concentration = 0.3 mM.  
 
 
Fig. 4. The effects of polyamine analogues:  spermine (S1), 
spermidine (SD1), norspermine (NS1), and norspermidine 
(NSD1) on biofilm formation in MRSA 252, NCTC 6571 
and MSSA 15981 cells. Concentration = 0.3 mM. 
CONCLUSIONS 
The distance between the amine groups and the 
symmetry in polyamines is a key factor in the SAR of 
polyamines disrupting biofilms. However, the 
mechanism of action of polyamines is still unclear. 
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 Abstract – We are investigating the effects of natural 
polyamines and their analogues in preventing biofilm 
formation in three Staphylococcus aureus strains which 
express biofilms of significantly different composition. 
The designed polyamine analogues contain two three-
carbon spacers between amino groups and this is 
apparently a requirement for biological activity. The 
biological activity differs depending upon the bacterial 





The growth in bacterial resistance due to biofilms 
creates an ever more significant challenge to global health. 
Bacterial biofilms are up to 100-1000-fold more resistant to 
antibiotics in comparison to free floating planktonic bacteria 
[1]. Norspermidine can display biofilm disrupting activity 
[2]. This activity is thought to be by interacting with 
polysaccharides [2]. This research project is aimed at 
developing novel polyamines that prevent biofilm formation 
and ultimately we hope to restore or enhance the activity of 
co-administered conventional antibiotics. 
 




Each polyamine (1 g each of spermidine, spermine, 
norspermidine, and norspermine) was dissolved in a 
sufficient amount of water. The aqueous solution was then 
cooled to 5 °C and paraformaldehyde (1 eq.) was added. The 
mixture was stirred for 1 h at 20 °C and then thoroughly 
extracted with chloroform. The resulting formaldehyde 
adducts were dissolved in anhydrous methanol followed by 
the dropwise addition of acrylonitrile with stirring under N2. 
After 15 h, more acrylonitrile was added and stirring was 
continued for a further 9 h. The acrylonitrile adducts were 
dissolved in ethanol. Pd/C catalyst (10% w/w of reactant) 
was added and the mixture was reduced under H2 (16 h) to 




 Bacteria (200 µL) were grown in 96-well plates at 37 °C 
in TSB medium containing 0.5 % glucose and different 
concentrations of polyamines. After 24 h growth, the plates 
were washed (3x with 0.9 % aq. NaCl) to remove planktonic 
bacteria and then dried at 60 °C for 1 h. Wells were then 
stained with 0.1% crystal violet solution and after 15 min 
the plates were washed with warm water. Acetic acid (30%, 
200 µL) was added and the visible absorbance was 
measured using a UV-visible plate reader at  = 595 nm. 
 
 
 To determine the composition of bacterial biofilms, 
bacteria were grown in 96-well plates at 37 °C in TSB 
medium with 0.5 % glucose. After 24 h growth, the plates 
were washed 3x with 0.9 % NaCl to remove planktonic 
bacteria. Sodium periodate, proteinase K, and DNase were 
added to wells and incubated for 4 h. The biofilm mass was 
then measured using the above crystal violet assay. 
 
RESULTS AND DISCUSSION 
 
 Three bacterial strains were used:  MRSA 252, NCTC 
6571, and MSSA 15981. Sodium periodate, proteinase K, 
and DNase, which disrupt biofilms containing 
polysaccharide, protein, or DNA, respectively, were used to 
determine the composition of bacterial biofilms. MRSA 252 
biofilms were only affected by proteinase K, indicating that 
these are protein-based biofilms. In contrast, NCTC 6571 
and MSSA 15981 showed polysaccharide-based biofilms as 
they were affected by sodium periodate, but neither by 
proteinase K nor by DNase. All the polyamines tested were 
inactive against the MRSA 252 biofilm. Spermine was 
inactive against NCTC 6571 and MSSA 15981. 
Norspermidine and norspermine, each containing two 3-
carbon spacers, were active against NCTC 6571, but not 
against MSSA 15981. Both the NCTC 6571 and MSSA 
15981 are polysaccharide-based biofilms, but only NCTC 
6571 was affected by norspermidine and norspermine. 
Therefore, from these results, there is either the possibility 
that certain polyamines disrupt biofilms by targeting specific 
polysaccharides of specific bacterial strains, or that 
polyamines have a different target and their mechanism of 




 The distance between the amine groups in polyamines is 
a key factor in the SAR of polyamines. Polyamines may 
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